PCV52 Temporal Trends in the Hospital Burden of Atrial Fibrillation and Stroke on Secondary Care Costs in England Between 2006 and 2009 (English)
- New search for: Bakhai, A.
- New search for: Righetti, C.
- New search for: Punekar, Y.
- New search for: Majeed, A.
- New search for: Bakhai, A.
- New search for: Righetti, C.
- New search for: Punekar, Y.
- New search for: Majeed, A.
In:
VALUE IN HEALTH
;
14
, 7
;
A373
;
2011
-
ISSN:
- Article (Journal) / Print
-
Title:PCV52 Temporal Trends in the Hospital Burden of Atrial Fibrillation and Stroke on Secondary Care Costs in England Between 2006 and 2009
-
Contributors:
-
Published in:VALUE IN HEALTH ; 14, 7 ; A373
-
Publisher:
- New search for: Blackwell Publishing Ltd
-
Publication date:2011-01-01
-
Size:A373
-
ISSN:
-
Type of media:Article (Journal)
-
Type of material:Print
-
Language:English
- New search for: 610
- Further information on Dewey Decimal Classification
-
Classification:
DDC: 610 -
Source:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Table of contents – Volume 14, Issue 7
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- A234
-
DA1 Artificial Neural Network Meta-Models in Cost-Effectiveness analysis of intensive Blood-Glucose Control: A Case Study Applied to the UK prospective Diabetes Study (UKPDS) Individual Patient outcome Simulation ModelAlam, M. / Briggs, A. et al. | 2011
- A235
-
PC2 Estimation of Productivity Costs Using the Friction Cost Method: New Evidence Using National DataErdogan-Ciftci, E. / Koopmanschap, M. A. et al. | 2011
- A236
-
PR3 Industry Preparedness against German reformsDevienne, E. / White, R. / Mukku, S. et al. | 2011
- A237
-
MT4 Mixed Treatment Comparisons Using Aggregate- and individual-Participant Level Data: An Efficient Use of Evidence for Cost-Effectiveness ModellingSaramago, P. / Sutton, A. J. / Cooper, N. J. / Manca, A. et al. | 2011
- A238
-
UT1 Combining DCE and TTO Into A Single Value FunctionVan Hout, B. A. / Oppe, M. et al. | 2011
- A239
-
VI3 Sequential Treatment of Follicular Non-Hodgkin Lymphoma: Cost-Effectiveness and Value of informationSoini, E. J. / Martikainen, J. A. / Vihervaara, V. / Mustonen, K. / Nousiainen, T. et al. | 2011
- A241
-
MA1 Mapping the EQ-5D Index from I-QOL in Idiopathic and Neurogenic OAB Patients: Results from A Cross-Sectional Study in the United States and Four European CountriesKay, S. / Tolley, K. / Globe, D. / Piercy, J. / Anderson, P. et al. | 2011
- A242
-
MO2 Extrapolation in Oncology Modelling: Novel Methods for Novel CompoundsAnnemans, L. / Asukai, Y. / Barzey, V. / Kotapati, S. / Lees, M. / Van Baardewijk, M. / Wang, Q. / Batty, A. J. / Fisher, D. et al. | 2011
- A243
-
RS3 Evidence, Process or Context? Examining The Factors That Drive Coverage Decisions Of Pharmaceuticals By Health Technology Assessment Bodies In EuropeCerri, K. / Ferná / ndez, J. L. / Knapp, M. et al. | 2011
- A244
-
PMD4 Expert Elicitation to Populate Early Health Economic Models of Medical Diagnostic Devices in DevelopmentHaakma, W. / Bojke, L. / Steuten, L. / Ijzerman, M. et al. | 2011
- A247
-
PMD20 Cost Analysis of Rechargeable Deep Brain Stimulator in DystoniaPr Coubes, P. / Fluck, L. / Topouchian, A. et al. | 2011
- A248
-
PMD25 Cost-Effectiveness of Transcatheter Aortic Valve Implantation (TAVI) in High-Risk or Inoperable Patients with Symptomatic Aortic Valve Stenosis in SpainFerreira-Gonzá / lez, I. / Serra, V. / Abdul, O. / Lizan, L. / Paz, S. / Banz, K. / Sureda, C. / Igual, A. / Garcia del Blanco, B. et al. | 2011
- A249
-
PMD31 Economic Evaluation of Primovist versus Extracellular Contrast in Imaging of Liver Metastases of Colorectal OriginCastell, J. / Bernal, C. / De Marcos, J. x. / Cugat, E. / Ramó / n, E. / Tellado, J. M. et al. | 2011
- A250
-
PMD37 Cost-Effectiveness of the Ex-Press Glaucoma Filtration Device in FranceDe jong, L. / Lafuma, A. / Clé / ment, O. / Aguade, A. S. / Berdeaux, G. et al. | 2011
- A251
-
PMD42 Cost-Effectiveness of Using the UGT1A1 Pharmacogenetic Test to Reduce the Incidence of Irinotecan Chemotherapy-related Febrile NeutropaeniaShabaruddin, F. H. / Elliott, R. A. / Tappenden, P. / Payne, K. et al. | 2011
- A253
-
PMD54 Resource Utilisation Related to Catheter-associated Urinary Tract infections in Swedish Spinal injury PatientsBruce, S. / Lö / froth, E. / Knutsson, B. / Bö / rstell, T. / Myré / n, K. J. et al. | 2011
- A254
-
PMD59 Complicated Parkinson'S Disease: Discrete Choice Analysis to Assess Patients' Preferences. A Pilot StudyLloyd, A. J. / Herdman, M. / Gonzalez, P. et al. | 2011
- A255
-
PMD64 The Effect of Supplementary Fees on the Diffusion of Medical Devices in the German System of Diagnosis related Groups (G-Drg): The Case of Drug-Eluting Stents in Patients with Acute Myocardial InfarctionBä / umler, M. et al. | 2011
- A257
-
PMD75 Patient Self-Testing of Oral Anticoagulation Therapy by CoaguChek® XS System. Rapid Health Technology Assessment in Slovak Health Care EnvironmentVisnansky, M. / Mesaros, S. et al. | 2011
- A258
-
PMD80 Patient Demographics and Surgical Expenditure in Hernia repair Surgical Cohorts Using A retrospective Nationwide Patient DatabaseHargreaves, J. A. / Nair, K. V. / Ghushchyan, V. H. / Allen, R. R. / Mcqueen, R. B. / Robinson, T. et al. | 2011
- A259
-
PMD85 Sleep Questionnaires Discriminate Between Participants With and Without Overactive Bladder SymptomsMargolis, M. K. / Coyne, K. / Jumadilova, Z. et al. | 2011
- A260
-
PSU5 Risk of Arthritis as A Predictor for the Misdiagnosis of Chondrolysis: An International Analysis of Clinical OutcomesSmith, J. C. / Provencher, M. T. / Solomon, D. J. / Navaie, M. et al. | 2011
- A261
-
PSU10 Economic Evaluation of Magnetic Resonance Guided Focused Ultrasound in Patients with Uterine Fibroids in GermanyAlvarez-Ossorio, L. / Burkowitz, J. / Nackunstz, I. / Brueggenjuergen, B. et al. | 2011
- A262
-
PSU15 the Economic Burden of Post-Transplant Events in Renal Transplant Patients in UK, Italy, Netherlands, Poland and BelgiumSennfalt, K. / Ling, C. / Pericleous, L. / Sbarigia, U. / Gatta, F. / Kolasa, K. / Zagorska, A. / Chamberlain, G. / Pandit, P. et al. | 2011
- A263
-
PSU21 Speech Problem and Health-Related Quality of Life in Head and Neck Cancer Survivors After Five Years of TreatmentsPayakachat, N. / Suen, J. Y. et al. | 2011
- A264
-
PSU26 Two-Year Changes in Generic and Obesity-Specific Quality of Life After Gastric BypassMar, J. / Arrospide, A. / Mar, B. / Martinez de Aragó / n, G. / Karlsson, J. et al. | 2011
- A265
-
PIN3 Comparing the Efficacy and Tolerability of Anti-Retroviral Therapy in Treatment-Naïve HIV-1 Infected Adults: A Systematic review of Randomized Clinical Trials and Bayesian Mixed Treatment Comparisons Including Atazanavir/R, Darunavir/R, Lopinavir/R, and EfavirenzVerheggen, B. / Vandeloise, E. / Treur, M. / Thuresson, P. O. / Lescrauwaet, B. et al. | 2011
- A266
-
PIN8 A Decision Tree Model Comparing Clinical Outcomes of Treatment with Telbivudine with or without “Tenofovir Add-on as Needed” and Lamivudine with or without “Tenofovir Add-on as Needed” in the Treatment of Chronic Hepatitis B Infection in TurkeyOzdemir, O. / Saylan, M. / Pakel, H. / Lescrauwaet, B. et al. | 2011
- A267
-
PIN13 Epidemiology of Staphylococcus Aureus Infections in Children: A Literature Review of the Last 10 YearsBricout, H. / Maier, W. / Mouchet, J. et al. | 2011
- A268
-
PIN18 Budget Impact Analysis of Tenofovir in Treatment of Chronic Hepatitis B (CHB)Gwiosda, B. / Krzystek, J. / Rys, P. / Wladysiuk, M. / Mierzejewski, P. / Kazmierski, M. / Plisko, R. et al. | 2011
- A269
-
PIN24 Potential Costs Associated with New Direct Acting Antiviral (DAAs) Therapy for Untreated Chronic Hepatitis C Genotype 1 Infection in the Veterans Health AdministrationChan, K. / Lai, M. N. / Groessl, E. J. / Hanchate, A. / Hernandez, L. / Wong, J. B. / Clark, J. A. / Asch, S. / Gifford, A. L. / Ho, S. et al. | 2011
- A270
-
PIN31 Quantifying the Financial and Disease Burden Associated with Mother to Child Transmission of HIV in UgandaKuznik, A. / Semeere, A. / Sempa, J. / Auerbach, B. / Lamorde, M. / Castelnuovo, B. / Hermans, S. / Ssewankambo, F. / Ssennono, M. / Mpanga Sebuyira, L. et al. | 2011
- A271
-
PIN36 Surgical Site Infection Incidence and Burden Assessment Using Multi-Institutional Real-World DataDelissovoy, G. / Pan, F. / Patkar, A. D. / Edmiston, C. E. / Peng, S. et al. | 2011
- A272
-
PIN41 Cost-Benefit Analysis of Regional Procured Essential Medicines in the Southern African Development Community (SADC) with a Focus on Access to Antiretroviral DrugsMiller-Jansö / n, H. E. / Stander, M. et al. | 2011
- A274
-
PIN53 Cost-Effectiveness Analysis of Pegylated Interferon Alpha-2A Versus Pegylated Interferon Alpha-2B in the Treatment of Chronic Hepatitis C Patients in PolandMacioch, T. / Paweska, J. / Niewada, M. / Berak, H. / Szkultecka-Debek, M. / Russel-Szymczyk, M. et al. | 2011
- A275
-
PIN58 Cost-Effectiveness Analysis of Pneumococcal 13-Valente Conjugate Vaccine Versus Pneumococcal 10-Valente Conjugate Vaccine in the Pediatric Immunization Routine, from the São Paulo State Public Health Care System (Brazil)Pepe, C. / Teich, V. / Mould, J. F. et al. | 2011
- A276
-
PIN63 Cost-Effectiveness Analysis of Anti-Pneumococcal Vaccines in PanamaLutz, M. A. / Luciani, K. / Morales, G. / Strutton, D. R. / Roberts, C. S. / Farkouh, R. A. / Cuesta, G. et al. | 2011
- A277
-
PIN68 Cost- Effectiveness Analysis of Human Papillomavirus Vaccination Program in RussiaOmelyanovsky, V. / Avxentyeva, M. / Krysanov, I. / Ivakhnenko, O. / Goryaynov, S. / Tsfasman, F. M. et al. | 2011
- A278
-
PIN73 Modeling the Long Term Clinical Outcomes and Health Care Cost Impact of Initiating Treatment with Atazanavir/R Compared with Darunavir/R, Lopinavir/R and Efavirenz for HIV-1 Infected Treatment-NaÏve Patients: Country Results for Italy, Spain, Portugal and UKThuresson, P. O. / Verheggen, B. / Heeg, B. / Aldir, I. / Carrasco, J. / Didoni, G. / Mesa, O. A. / Lescrauwaet, B. et al. | 2011
- A279
-
PIN78 Cost Utility of Infant Vaccination Against Respiratory Syncytial Virus Infection in the NetherlandsMeijboom, M. / Rozenbaum, M. / Benedictus, A. / Luytjes, W. / Kneyber, M. / Wilschut, J. / Hak, E. / Postma, M. et al. | 2011
- A280
-
PIN83 Cost-Effectiveness and Cost-Utility analysis of 200 Days Prophylaxis of Cytomegalovirus (CMV) infections in High Risk (D+/R-) Kidney Transplant Recipients in PolandKawalec, P. / Holko, P. / Boratynska, M. / Glyda, M. / Ignacak, E. / Russel-Szymczyk, M. / Szkultecka-Sebek, M. / Kaweczynska-Lason, A. et al. | 2011
- A282
-
PIN94 Assessment of Health Related Quality of Life (HRQOL) in Hepatitis- B PatientsHaq, N. / Shafie, A. A. / Hassali, M. A. / Ibrahim, M. I. / Saleem, F. et al. | 2011
- A283
-
PIN99 Modelling the Impact of Extended Vaccination Strategies on the Epidemiology of PertussisRozenbaum, M. H. / De vries, R. / Postma, M. J. / Le, H. H. et al. | 2011
- A284
-
PIN105 Financial Support for HIV/AIDS Prevention, Care and Treatment in ThailandLayton, M. R. / Pachanee, K. / Prakongsai, P. et al. | 2011
- A285
-
PIN110 Development of A Large Safety Database Using Studies Conducted During the Clinical Development and Post-Marketing of A Virosomal Aluminium-Free Hepatitis A VaccineFaure, C. / Koller, A. / Hartmann, K. / Chré / tin, S. / Doux, S. / Visè / le, N. / Bugnard, F. / Maier, W. et al. | 2011
- A286
-
PMH2 The Efficacy of the New Antidepressant Agomelatine as Compared Against Placebo and SSRIS: A Meta-Analysis Combining Published and Unpublished DataBallesteros, J. / Tarapues, M. / Santos, B. / Rueda, J. R. et al. | 2011
- A287
-
PMH7 Aasenapine Versus Other Antipsychotics in Bipolar I Disorder: Indirect Comparisons at Twelve WeeksSapin, C. / Corson, H. / Beillat, M. / Hansen, K. et al. | 2011
- A288
-
PMH12 Risk of Relapse and Hospitalization in the 2-Year Open-Label Treatment of Outpatients with Schizophrenia Randomized to Olanzapine Long-Acting Injection or Oral OlanzapineNovick, D. / Ascher-Svanum, H. / Bertsch, J. / Detke, H. / Mcdonnell, D. / Witte, M. / Haro, J. et al. | 2011
- A289
-
PMH17 The Economic and Social Consequences of Schizophrenia Treatment with Seroquel XR® (Quetiapine Prolonged Release Tablets) in Poland: Aanalysis of the Impact on the Health Care SystemFaluta, T. / Rdzanek, M. / Pierzgalska, K. / Wró / bel, B. et al. | 2011
- A290
-
PMH23 The Economic Burden of Mental Ill Health in the Workplace: A Costing Approach for Brazilian EmployersReis, T. C. / Takemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Cukier, F. N. / Santos, P. M. / Cruz, R. B. / Ribeiro, A. C. / Fernandes, R. R. et al. | 2011
- A291
-
PMH29 Cost Effectiveness of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Turkey in Patients with Major Depressive Disorder (Mdd) Who Have Failed Previous Antidepressant TherapyAydemir, O. / Dilbaz, N. / Malhan, S. et al. | 2011
- A292
-
PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in NorwayEinarson, T. R. / Vicente, C. / Zilbershtein, R. / Piwko, C. et al. | 2011
- A293
-
PMH40 Economic Evaluation of Agomelatine for Major Depressive Disorder in AustraliaO'Leary, B. A. / Hamann, G. B. / Adena, M. A. et al. | 2011
- A294
-
PMH46 The Quality of Life of Children With ADHD and their Parents: Results of EQ-5D and Kidscreen-10Van Der Kolk, A. / Bouwmans, C. / Schawo, S. / Buitelaar, J. B. / van der Gaag, R. J. / Van agthoven, M. / Hakkaart-van Roijen, L. et al. | 2011
- A295
-
PMH51 Measuring Relapse After Substance Abuse Treatment: A Proportional Hazard ApproachCiesla, J. / Mazurek, K. et al. | 2011
- A296
-
PMH56 Negative Symptoms Have Greater Impact on Functioning Than Positive Symptoms in Schizophrenia: Analysis of Catie DataRabinowitz, J. / Garibaldi, G. / Levine, S. / Bugarski-Kirola, D. / Berardo, C. / Kapur, S. et al. | 2011
- A297
-
PMH61 A Descriptive Analysis of Atomoxetine Utilization in Attention Deficit/Hyperactivity Disorder (ADHD) the United Kingdom and ItalySikirica, V. / Mitra, D. / Fridman, M. / Davis, K. L. / Hodgkins, P. et al. | 2011
- A298
-
PMH66 12-Year Trend Analysis on the Characteristics, Primary Payer, and Prescribed Medications of Physician-Office Visits for Patients with Dementia in the United StatesChen, Y. J. / Sankaranarayanan, J. / Murman, D. L. et al. | 2011
- A300
-
PMH77 Prescription Pattern Evaluation for Bipolar Disorder in a Treatment Facility in IndiaNagappa, A. N. / Kumar, M. / Noorunnisa, S. / Bhandary, P. V. / Veerupaksh, D. / Balakrishnan, R. et al. | 2011
- A301
-
PMH83 Estimating Utilities in Schizophrenic and Bipolar Patients from Disease-Specific or Generic Instruments Assessing Patients' Health States: Where are the Differences?Cuervo, J. / Rebollo, P. / Maurino, J. / Cordero, L. / Castejó / n, N. et al. | 2011
- A303
-
PMS10 Evaluation the Risk Factors of Second Hip Fractures in the ElderlySebestyé / n, A. / Sá / ndor, J. / Patzai, B. / Gõ / cze, K. / Kriszbacher, I. / Mintá / l, T. et al. | 2011
- A304
-
PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured PopulationSchabert, V. / Gandra, S. R. / Watson, C. / Fox, K. M. / Yeaw, J. / Goodman, S. / Milev, S. / Harrison, D. J. et al. | 2011
- A305
-
PMS20 Treatment of Patients with Moderate and Severe Psoriasis – Cost-of-Illness in the Czech RepublicPetrikova, A. / Klimes, J. / Dolezal, T. / Marinov, L. / Petrova, G. et al. | 2011
- A307
-
PMS31 Cost-Effectiveness of Abatacept for the Treatment of Rheumatoid Arthritis (RA) After the Failure of a First TNF inhibitor in the United KingdomPericleous, L. / Lebmeier, M. et al. | 2011
- A308
-
PMS36 Economic Analysis of Etanercept in Rheumatoid Arthritis from a Public perspective in ColombiaFernandes, R. A. / Tovar, D. A. / Mould, J. F. et al. | 2011
- A309
-
PMS41 Assessing the Cost Effectiveness of Broadening Access to Alendronate for the Prevention of Osteoporotic Fracture in AustraliaTilden, D. / Jackson, D. / Tay-Teo, K. / Van Bavel, J. et al. | 2011
- A310
-
PMS46 Cost-Utility Analysis of Certolizumab Pegol versus Alternative Tumor Necrosis Factor-Inhibitors, for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in SpainVilloro, R. / Hidalgo, A. / Ferro, B. / Talavera, P. et al. | 2011
- A311
-
PMS51 A Cost Utility Analysis of Anti-TNF Agents for the Treatment of Rheumatoid ArthritisAdams, R. C. / Walsh, C. / Schmitz, S. / Barton, P. / Barry, M. et al. | 2011
- A312
-
PMS56 Subjective Health Expectations of Rheumatoid Arthritis Patients Starting Biological TherapyGulacsi, L. / Brodszky, V. / Baji, P. / Gulacsi, L. x. / Pé / ntek, M. et al. | 2011
- A314
-
PMS67 Determining the True Impact of Dupuytren'S Disease: A Qualitative StudyWilburn, J. / McKenna, S. / Crawford, S. R. / Perry-Hinsley, D. / Bayat, A. et al. | 2011
- A315
-
PMS72 Assessment of Prior Use of Prescribed Pain Medications Among Elderly Patients Who Initiated DuloxetineChen, S. Y. / Peng, X. / Wu, N. / Bernauer, M. / Rao, P. / Boulanger, L. / Zhao, Y. et al. | 2011
- A316
-
PMS77 Improving Quality and Reducing Costs in Workers' Compensation Health Care: A Population-Based Intervention StudyWickizer, T. M. / Franklin, G. M. / Fulton-Kehoe, D. et al. | 2011
- A317
-
PND3 Risk-Benefit Analysis of Therapy in Multiple SclerosisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
- A318
-
PND9 The Role of Spontaneous Events Databases for Benefit-Risk AnalysisQizilbash, N. / Mé / ndez, I. / Sá / nchez-de la Rosa, R. et al. | 2011
- A319
-
PND14 Comparing Expected Costs associated with Three Screening Strategies for Cystic Fibrosis Along SpainRamos-Goñ / i, J. M. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. / Espada-Sá / enz-Torre, M. / Tellerí / a-Orriols, J. J. et al. | 2011
- A320
-
PND20 A Cost-of-Illness Analysis Of Amyotrophic Lateral Sclerosis In GreeceAthanasakis, K. / Sideris, M. / Zacharis, M. / Rentzos, M. / Evdokimidis, I. / Kyriopoulos, J. et al. | 2011
- A321
-
PND25 Use of Drug Reimbursement as Markers of Disease for Epidemiological and Direct Cost analysis: The Case of Epilepsy in FranceFagnani, F. / Kusnik-Joinville, O. / de Zé / licourt, M. / Levy-Bachelot, L. / Branchoux, S. / Murat, C. / Bertrand, M. / Kahane, P. et al. | 2011
- A322
-
PND31 A Modelled Economic Evaluation of Firazyr® (Icatibant) for Symptomatic Treatment of Acute Attacks of Hereditary Angioedema (HAE) in Adults with C1-Esterase-Inhibitor (C1-INH) DeficiencyTilden, D. / Cottrell, S. / Tocchini, L. / Jayaram, N. / Sinani, R. / Barnes, D. et al. | 2011
- A323
-
PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III TrialO' / Connor, P. / Briggs, A. / Carita, P. / Bego-Le-Bagousse, G. et al. | 2011
- A324
-
PND41 Predicting EQ-5D Utility Scores from the Huntington quality of Life instrument (H-QOL-I)Clay, E. / Briquet, B. / Aballea, S. / Maman, K. / Toumi, M. et al. | 2011
- A325
-
PND46 The Huntington Quality of Life Instrument (H-QOL-I): Cross-Cultural Validation in Germany, Poland and USAClay, E. / Mraidi, M. / Zielonka, D. / Cohen, J. / Toumi, M. / Auquier, P. et al. | 2011
- A326
-
PND51 The Relationship Between Patient-Reported Health-Related Quality of Life and Disability Status Among Patients with Multiple SclerosisKhalaf, K. M. / Globe, D. / Armstrong, E. / Malone, D. / Coyne, K. et al. | 2011
- A327
-
PND56 Quality of Life Assessments in Adults with Attention Deficit/Hyperactivity Disorder - A Systematic ReviewMarfatia, S. / Shroff, K. / Munshi, S. / Tiwari, A. et al. | 2011
- A328
-
PND61 Impact of Patient Cost-Sharing Arrangements for Disease Modifying Therapies on Treatment Compliance among Patients with Multiple Sclerosis in the United StatesPalmer, L. A. / Fowler, R. / Shi, N. / Dastani, H. / Abouzaid, S. / Kim, E. et al. | 2011
- A329
-
PND66 Cross-Cultural Adaptation and Validation of the Brazilian Version of the Fatigue Severity Scale (FSS)Toledo, F. O. / Junior, W. M. / Speciali, J. G. / Sobreira, C. F. et al. | 2011
- A330
-
PUK3 Sources of Heterogeneity Among Overactive Bladder Clinical Trial Estimates of Tolterodine and Fesoterodine Reductions of Urgency Urinary Incontinence Episodes Relative to PlaceboSnedecor, S. J. et al. | 2011
- A331
-
PUK9 Comparative Cost Analysis of Treatment for Renal Anemia with Methoxy Polyethylene-Glycol Erythropoietin Beta (MIRCERA®) Versus Erythropoietin Beta (NEORECORMON®)Medina Gó / mez, J. L. et al. | 2011
- A332
-
PUK14 Trends in Rate and Cost of Hospitalizations Due to Chronic Kidney Disease (CKD) in the United StatesAggarwal, S. et al. | 2011
- A333
-
PHP3 Patient Preferences Considering the Choice of Health Care Providers in Hungary – Results From Discrete Choice ExperimentBaji, P. / Pavlova, M. / Gulacsi, L. / Groot, W. et al. | 2011
- A334
-
PHP9 Temporary Use Authorizations: The Economic and Clinical Future of Drugs Used in the French Compassionate ProgramDegrassat-Thé / as, A. / Paubel, P. / Parent de Curzon, O. / Le Pen, C. / Sinè / gre, M. et al. | 2011
- A335
-
PHP14 Multiple Indication Pricing, Reimbursement and Funding Dynamics: The Case of Orphan IndicationsWild, L. / Forster, L. et al. | 2011
- A336
-
PHP21 Adoption of New Medicines in the OECD: Regulation, Innovation and ScaleVarol, N. / Costa-i-Font, J. / Mcguire, A. J. et al. | 2011
- A337
-
PHP26 Health Outcomes and Economics Research for Regenerative Medicine and Cellular Therapies: Lessons From A Multi-Market Health Technology Assessment and Reimbursement reviewFaulkner, E. C. / Fernandez, M. / Spinner, D. S. et al. | 2011
- A338
-
PHP31 The Economic Impact of Switches of Prescription Drugs to the Over-the-Counter Status (Rx-to-OTC): A Systematic Literature ReviewKarray, S. M. / Plich, A. / Flostrand, S. / Toumi, M. et al. | 2011
- A339
-
PHP37 Regional Drug Evaluation in Spain: A Comparison Among CommitteesHerná / ndez-Pastor, L. J. / Huerta, A. et al. | 2011
- A340
-
PHP42 Drug Consumption in Bosnia and Herzegovina - Comparison to Neighboring CountryKrehic, J. / Gavrankapetanovic, F. / Djapo, M. / Agic, N. et al. | 2011
- A341
-
PHP48 Croatian Pharmaceutical Expenditure Before and After Healthcare Reform – Comparison to EU CountriesPogorilic, S. / Vitezica, P. / Bolanca, S. et al. | 2011
- A342
-
PHP54 Predictors of Avoidable Emergency Room Visits Among High Cost Medicaid EnrolleesGanduglia, C. / Franzini, L. / Dunn, K. et al. | 2011
- A343
-
PHP59 Estimation of Increases in Direct Medical Expenditures Associated with Medication Nonadherence and Potential Savings from Increased AdherenceHicks, K. A. / Karve, S. J. / Vlahiotis, A. / Frazee, S. G. / Tian, Y. / Earnshaw, S. R. et al. | 2011
- A344
-
PHP64 Reorganisation of Hospital Emergency Services: A Business Case for Quality ImprovementEichler, K. / Senn, O. / Rü / themann, I. / Bö / gli, K. / Sidler, P. / Brü / gger, U. et al. | 2011
- A345
-
PHP70 Value Based Pricing (VBP): Is This the Way Forward for the UK NHS?Comberiati, U. / Dass, R. N. / White, N. et al. | 2011
- A346
-
PHP75 The Cost Per Day of Intensive Care Units (ICU) in France: The CRRÉA StudyGarrigues, B. / Lefrant, J. Y. / Bazin, J. / Bardoulat, I. / Tagdichti, K. / Courtial, F. / Maurel, F. / Pribil, C. et al. | 2011
- A347
-
PHP80 Where A Cheap Medicine is Not the Same as A Generic Medicine: The Belgian CaseDylst, P. / Vulto, A. / Simoens, S. et al. | 2011
- A348
-
PHP86 Incorporating the Patient Perspective Into the Health Care Process: Experience from the C.A.T. Health SystemRebollo, P. / Castejó / n, N. / Cuervo, J. / Igarreta, M. / Ortega, F. et al. | 2011
- A349
-
PHP92 Lack of Clinical Efficacy as a Main Reason for Ahtapol Negative Recommendations for Orphan Oncology DrugsOfierska-Sujkowska, G. / Jagodzinska-Kalinowska, K. / Matusewicz, W. / Pasierski, T. et al. | 2011
- A350
-
PHP97 Use of Paediatric “Observation Status” and Effect on in-Patient Admission Rate in Accident and Emergency (A&E) DepartmentsLaokri, S. / Zhang, W. H. / Ben Hamed, N. / Cohen, L. / De Wever, A. / Alexander, S. et al. | 2011
- A351
-
PHP103 Global Health Care Reforms and Pricing, Access and Health Outcomes StrategyAggarwal, S. et al. | 2011
- A352
-
PHP108 Public Health and Prevention in Europe: Is it Cost-Effective?Simoens, S. et al. | 2011
- A353
-
PHP113 Measuring the Organizational Performance in Tennessee: A Case of Community HospitalsRoh, C. Y. / Shirore, R. M. et al. | 2011
- A354
-
PHP119 Is There No Optimal Approach for Orphan Drugs to Patient Access? Rare Disease is Not Rare and Needs to Develop the New Pricing and Reimbursement SolutionKim, S. / Cho, Y. / Shim, S. / Lee, J. / Kim, W. / Bae, K. et al. | 2011
- A355
-
PHP124 Personalized Decision Making in Cancer Medicine? Systematic Overview of HTA Procedures and Specific Approaches in Ten Countries Across Four ContinentsSchwarzer, R. / Rochau, U. / Mü / hlberger, N. / Jahn, B. / Sroczynski, G. / Schnell-Inderst, P. / Schall, I. / Kallinger, S. / Lackner, M. et al. | 2011
- A356
-
PHP129 Societal Preferences for Health Technology Disinvestment Policy: Views of Scottish Taxpayers – A Qualitative StudyHislop, J. M. et al. | 2011
- A357
-
PHP134 Comparison of the Knowledge in Standard Treatment Guidelines among Medical Practitioners and Medical StudentsHettihewa, L. M. / Wimalasena, G. / Tharanga, D. et al. | 2011
- A359
-
PHP146 Current Status and Trends in Performance-Based Schemes Between Health Care Payers and ManufacturersCarlson, J. J. / Gries, K. / Sullivan, S. D. / Garrison, L. et al. | 2011
- A360
-
PHP151 Evidence on the Impact of Managed Entries on Payers, Patients, Manufacturers, and Health Care WorkersFerrario, A. / Nicod, E. / Kanavos, P. et al. | 2011
- A361
-
PHP157 Using the CEAC for Value Based Pricing: Don'T Change the GoalpostsRoberts, G. et al. | 2011
- A363
-
PHP168 Endogenous Cost-Effectiveness Analysis in Health Care Technology AdoptionJena, A. B. / Philipson, T. J. et al. | 2011
- A364
-
PCV5 Thromboembolisms with Thrombopoietin Receptor Agonists: Systematic Review and Meta-Analysis of Randomized Controlled TrialsCorrales-Á / lvarez, I. / Catalá / pez, F. / Martí / n-Serrano, G. / Montero-Corominas, D. / Calvo-rojas, G. et al. | 2011
- A366
-
PCV15 Guidelines Adherence and Hypertension Control in Patients Suffering from Cardiovascular DiseaseAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. et al. | 2011
- A367
-
PCV19 Prescription of Angiotensin Converting Enzyme Inhibitors and Hypertension Control in Diabetic Hypertensive PatientsAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Saleem, F. / Atif, M. et al. | 2011
- A368
-
PCV25 Characterising Patients with A First-Time Admission for atrial Fibrillation in the United KingdomJones, J. / Townsend, R. / Jameson, K. / Amber, V. / Evans, L. M. et al. | 2011
- A370
-
PCV37 Parametric Conditional Non-Frailty Model for Recurrent Events in Persons with Type 2 Diabetes in Sweden: The Example of Myocardial InfarctionAhmad Kiadaliri, A. / Clarke, P. M. / Gerdtham, U. G. / Nilsson, P. / Eliasson, B. / Gudbjö / rnsdottir, S. / Steen carlsson, K. et al. | 2011
- A371
-
PCV42 A Budget Impact analysis to Estimate the Economic Impact of Sevikarhct® for the Treatment of Arterial Hypertension in SpainDarba, J. / Kaskens, L. / Nilsson, J. / Oberdiek, A. et al. | 2011
- A372
-
PCV47 Analysis of Transient Ischemic Attack-Related Clinical Outcomes, Health Care Utilization and Cost Burden of Patients with Non-Valvular Atrial FibrillationBaser, O. / Wang, L. et al. | 2011
- A373
-
PCV53 Cost Study of Caregiving for Patients with Chronic Symptomatic Heart Failure in Spain, Insights from the Inoescaro StudyMarti, B. / Delgado, J. / Oliva, J. / Llano, M. / Pascual, P. / Comin, J. / Grillo, J. J. / Diaz molina, B. / Culebras, J. / Martí et al. | 2011
- A376
-
PCV70 Cost Effectiveness of Ticagrelor in the Treatment of Acute Coronary Syndrome in GermanyTheidel, U. / Asseburg, C. / Giannitsis, E. / Katus, H. et al. | 2011
- A377
-
PCV76 A Cost-Effectiveness Analysis of Clopidogrel in Patients with Non Stable Acute Coronary Syndrome in GreeceKourlaba, G. / Fragoulakis, V. / Maniadakis, N. et al. | 2011
- A378
-
PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome: Results from the Plato Study: A Canadian AnalysisMittmann, N. / Chan, B. / Seung, S. J. / Liovas, A. / Cohen, E. et al. | 2011
- A379
-
PCV86 Long-Term Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome (ACS) from A Mexican Public and Private Health Care Perspective Based on Data from the Plato TrialGarcia-Castillo, A. / De-los-Rios, M. / Polanco, A. C. / Ramirez, M. A. / Nikolic, E. / Mellströ / m, C. et al. | 2011
- A380
-
PCV91 Cost-Effectiveness of Endovascular Treatment Versus Open Surgery in Patients with Steno-Occlusive Disease of the Femoral ArteryRamos-Goñ / i, J. M. / Mar-Medina, J. / Valcá / rcel-Nazco, C. / Castilla-Rodrí / guez, I. et al. | 2011
- A382
-
PCV102 Evaluation of the Measurement Properties of the Antihypertensive Adherence SurveyHudgens, S. / Lynch, J. / Pasquale, K. / Zacker, C. et al. | 2011
- A383
-
PCV107 Correlation of Physician-Rated Adherence with Therapeutical Outcomes in Antihypertensive Treatment: Pooled Analysis Findings from Six Valsartan Studies Including 15,583 Available PatientsVilla, L. / Abraham, I. / Macdonald, K. / Denhaerynck, K. et al. | 2011
- A384
-
PCV112 A Comparison of European Health Care Systems on Stroke Prevention in Atrial Fibrillation – Interim Results of a Patient Satisfaction SurveyOberdiek, A. / Sandberg, A. / Franczok, E. et al. | 2011
- A386
-
PCV123 The Participation Decision for Lifestyle Disease ScreeningSø / gaard, R. / Lindholt, J. / Gyrd-Hansen, D. et al. | 2011
- A387
-
PCV128 A Real World Evaluation to Describe the Characteristics, Outcomes and Resource Use Associated with Patients Being Managed by a Secondary Care Based Anticoagulation ServiceRose, P. / James, R. / Chapman, O. / Marshall, S. et al. | 2011
- A388
-
PCV134 Concomitant Medciation Use in US Adults on Statin Therapy: Findings from a Multi-Employer Claims DatabaseMolife, C. / Zhu, Y. / Yu, C. / Mccracken, R. / Zhao, Z. et al. | 2011
- A389
-
PCV139 Epidemiology and Economic Burden of Atrial Fibrilation to the Public Health Care System in BrazilNasciben, V. / Piegas, L. S. / Figueiredo, M. J. / Martins, S. C. et al. | 2011
- A391
-
PGI2 The Relationship Between Acute and Chronic Acetaminophen Exposure and Liver ToxicityGokhale, M. N. / Foster, H. R. / Cleves, M. / Hogan, W. R. / James, L. P. / Martin, B. et al. | 2011
- A392
-
PGI7 Impact of Complications from Dysphagia on Hospital Charges in the United StatesJensen, I. S. / Helm, T. / Cyr, P. L. et al. | 2011
- A393
-
PGI13 Evaluation of the Clinical and Economic Burden of Chronic Constipation in BelgiumLeeuwenkamp, O. / Chevalier, P. / Lamotte, M. et al. | 2011
- A394
-
PGI18 Treatment of Chronic Hepatitis C Patients with Peginterferon Alfa-2a or Peginterferon Alfa-2b: A Cost-Effectiveness Analysis for the Portuguese NHS SettingAreias, J. / Branco, T. / Calinas, F. / Carvalho, A. / Macedo, G. / Manata, M. J. / Matos, L. / Rodrigues, B. / Velosa, J. / Pereira, C. et al. | 2011
- A395
-
PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada: Analyses with the Ramq DatabaseLachaine, J. / Yen, L. / Beauchemin, C. / Hodgkins, P. et al. | 2011
- A396
-
PGI28 Disease-Specific Health-related Quality of Life in Patients with Quiescent Ulcerative Colitis: Effects of one Year Maintenance Treatment with MMX MesalamineSolomon, D. / Yarlas, A. / Yen, L. / Hodgkins, P. / Karlstadt, R. / Kane, S. V. et al. | 2011
- A397
-
PGI33 Predictors of Direct Medical Costs of Crohn'S Disease and Ulcerative ColitisStark, R. G. / Hunger, M. F. / Reitmeir, P. / Kö / nig, H. H. / Leidl, R. et al. | 2011
- A398
-
PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special PopulationsPaes, B. A. / Li, A. / Lanctot, K. L. / Mitchell, I. et al. | 2011
- A399
-
PIH12 Patients with BPH in France: Results at Six Months with Phytotherapy Versus Other TreatmentsPerrin, P. / Auges, M. / Rahhali, N. / Taieb, C. et al. | 2011
- A400
-
PIH18 Rotavirus Gastroenteritis in Vulnerable Children: A UK Case Control StudyPockett, R. D. / Campbell, D. / Adlard, N. E. / Rajoriya, F. / Carroll, S. M. et al. | 2011
- A401
-
PIH23 Cost-Effectiveness of Guanfacine Extended Release as an Adjunctive Therapy to a Psychostimulant Compared to Psychostimulant Monotherapy for the Treatment of Attention Deficit/Hyperactivity Disorder in Children and AdolescentsSikirica, V. / Erder, M. / Xie, J. / Macaulay, D. / Diener, M. / Hodgkins, P. / Wu, E. Q. et al. | 2011
- A402
-
PIH28 Economic Evaluation of Pneumococcal Conjugated Vaccines for ArgentinaEllis, A. / Lepetic, A. C. / Gomez, J. A. et al. | 2011
- A403
-
PIH34 Patient Reported Reasons for Medication Nonadherence: A SurveyLee, K. / Nixon, M. / Cascade, E. / Plummer, C. / Law, V. / Lee, M. et al. | 2011
- A405
-
PIH45 Burden of Herpes Zoster and Post-Herpetic Neuralgia: Findings from a Cross-Sectional Patient Reported Outcomes StudyCarroll, S. / Gater, A. / Abetz, L. / Demuth, D. / Smith, F. / Mannan, A. et al. | 2011
- A406
-
PIH50 quality of Life of Students from the Faculty of Pharmacy at Medical University of Warsaw in 2011Zawodnik, S. / Kiljan, A. / Hermanowski, T. / Golicki, D. et al. | 2011
- A408
-
PIH62 Comparative Pricing and Reimbursement Analysis in Four East European CountriesPeev, S. / Petrova, G. / Baran, A. / Petrikova, A. / Daneasa, D. et al. | 2011
- A409
-
PIH67 Successful Development of Annual and Long Term Prediction Models to Estimate Height Outcome following Growth Hormone (GH) Therapy in Children Using Data from KIGS – A Large Pharmacoepidemiological SurveyLoftus, J. / Ranke, M. / Lindberg, A. / Brosz, M. / Kaspers, S. / Wollmann, H. / Koltowska-Haggstrom, M. / Roelants, M. et al. | 2011
- A410
-
PSY4 Comparison of Infliximab and Ustekimumab for Treatment of Moderate to Severe Psoriasis: a Mixed Treatment Meta-AnalysisFan, T. / Bennett, H. / Smith, N. / Marin, M. / Sen, S. et al. | 2011
- A412
-
PSY15 Striving for Affordable Treatments Within the Greek Environment: Do Epoetin Biosimilars Help?Kani, C. / Litsa, P. / Alexopoulou, E. / Hatzikou, M. / Delibasi, S. / Geitona, M. et al. | 2011
- A413
-
PSY20 The Annual Direct Medical Cost of Systemic Lupus Erythematosus (Sle) Patients and Costs Drivers (Lucie Study): French ResultsAmoura, Z. / Pennaforte, J. L. / Hamidou, M. / Arfi, S. / Lazaro, E. / Hachulla, E. / Pourrat, J. / Queyrel, V. / Aubin, C. / Garofano, A. et al. | 2011
- A414
-
PSY25 What is the Economic Impact of Obesity on Hospital Inpatient Care?Pereira, J. / Ribeiro, V. / Mateus, C. et al. | 2011
- A415
-
PSY31 Cost-Effectiveness of Tapentadol Prolonged-Release (Pr) Compared to Oxycodone Controlled Release (Cr) in Patients with Chronic Severe Non-Cancer Pain in IrelandObradovic, M. / Ikenberg, R. / Hertel, N. / Liedgens, H. et al. | 2011
- A416
-
PSY36 Modelling the Cost-Effectiveness of Orlistat as a Treatment for Obesity in Primary CareAra, R. / Blake, L. et al. | 2011
- A417
-
PSY42 Chronic Pain: Patient Treatment Preferences - a Discrete Choice ExperimentMü / hlbacher, A. / Ezernieks, J. / Nü / bling, M. et al. | 2011
- A418
-
PSY47 Evaluating the Cross-over Effect on Health-related Quality of Life in a Randomized Cross-over Study of Hemophilia-A PatientsJo, H. / Gringeri, A. / Leissinger, C. / Mantovani, L. / Cortesi, P. / Gemmen, E. et al. | 2011
- A419
-
PSY53 Changes in Concomitant therapy for Weight-related Illness Following Initiation of Weight Loss PharmacotherapyAgatep, B. C. / Charland, S. L. / Herrera, V. / Hawk, G. / Stanek, E. J. et al. | 2011
- A420
-
PSY58 Responsiveness of the Treatment Satisfaction with Medicines Questionnaire (Satmed-Q) in a Longitudinal Sample of Patients with Neuropathic PainRejas, J. / Ruiz, M. A. / Pardo, A. / Ruiz, L. / Soto, J. et al. | 2011
- A421
-
PRM5 Novel Patient Reported Outcomes and Data Tool for Chronic Disease Management (PROCDIM): Case in Point Prostate CancerAggarwal, S. et al. | 2011
- A422
-
PRM11 Learning Effect in Economic Evaluations of Health Care InterventionsChang, S. / Sungher, D. / Diamantopoulos, A. et al. | 2011
- A423
-
PRM17 Suitability of CLAD-CQR Models for Obtaining QALYsCunillera, O. / Vilagut, G. / Medina, A. / Tresserra, R. / Alonso, J. / Brugulat, P. / Garcí / a, C. / Ferrer, M. et al. | 2011
- A424
-
PRM22 Microsimulation Methods Used for Health Policy Decisions in Personalized Medicine Under Constrained ResourcesJahn, B. / Rochau, U. / Mü / hlberger, N. / Sroczynski, G. / Conrads-Frank, A. / Siebert, U. et al. | 2011
- A425
-
PRM27 Modelling the Brazilian Extended Consumer Price Index for Pharmaceutical Products: Comparison Between Exponential Smoothing and Box-Jenkins MethodsSantos, P. M. / Takemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Takemoto, M. M. / Fernandes, R. R. / Padula, A. C. / Cukier, F. N. / Cruz, R. B. et al. | 2011
- A426
-
PRM33 Systematic Review of Health State Utilities in SpainGarcí / a-Pé / rez, L. / Aguiar-Ibá / ez, R. / Linertová / R. / Rivero-Santana, A. / Abá / solo-Alessó et al. | 2011
- A428
-
PRM44 The First Research: Assessment of the WTP Threshold for QALY by Contingent Valuation Method in RussiaZelenova, O. et al. | 2011
- A429
-
PRM49 Evaluation of Bivariate Meta-analysis Methods to Synthesise Results of Several Studies with Two Correlated EndpointsAballea, S. / Vataire, A. L. / Neine, M. E. / Le coroller, G. / Toumi, M. et al. | 2011
- A430
-
PRM55 A New Approach to Modeling Cancer Recurrence and Follow-UpRose, J. / Augestad, K. M. / Cooper, G. / Meropol, N. J. et al. | 2011
- A431
-
PRM60 Assessing Relative Clinical Value Across Tumor Types in Metastatic DiseaseKarweit, J. / Nanavati, S. / Van Baardewijk, M. / Wagner, S. / Kotapati, S. et al. | 2011
- A432
-
PRM66 Comparison of Reconciliation and Review Methodologies for the Translation of Patient Reported Outcome (PRO) MeasuresVerjee-Lorenz, A. / Two, R. / Clayson, D. / Miller, F. et al. | 2011
- A433
-
PCN3 Cetuximab for the First-Line Treatment of Metastatic Colorectal CancerUbago, R. / Castillo, M. A. / Flores, S. / Rodriguez, R. / Beltran, C. et al. | 2011
- A434
-
PCN8 Incidence, Predictive Factors, and Infection Complications of Prolonged Neutropenia in R-CHOP/CHOP Treated Diffuse Large B-Cell Lymphoma PatientsZhou, K. R. / Kei, K. M. / Ng, H. M. / Wong, R. S. et al. | 2011
- A435
-
PCN12 Dasatinib or Imatinib in Newly Diagnosed Chronic Myeloid Leukemia Patientes in the Chronic Phase: Five-Years Follow-up Simulated CohortDarba, J. / Perez-Alvarez, N. / Kaskens, L. / Martin, P. et al. | 2011
- A437
-
PCN23 Survival Analyses Adjusted for Crossover in Relapsed Multiple Myeloma: Results of the Apex TrialPacou, M. / Gauthier, A. / Abrams, K. / Spencer, M. et al. | 2011
- A438
-
PCN29 Budgetary Impact of Adoption of Erlotinib for Lung Cancer in the Private Health Insurance Market in Brazil: A Real World Data AnalysisClark, O. / Clark, L. G. / Botrel, T. E. / Medina, P. / Paladini, L. / Rosa, B. / Rodrigues, N. / Fortes, A. F. / Castro, A. P. / Faleiros, E. et al. | 2011
- A439
-
PCN34 Cost Analysis of Anemia Treatment with Erythropoiesis-Stimulating Agents (ESAs) in Cancer Patients Receiving Chemotherapy in ItalyDuran, A. / Spaepen, E. / Lamotte, M. / Lucioni, C. / Kutikova, L. / Pujol, B. / Gozzo, M. / Annemans, L. et al. | 2011
- A440
-
PCN39 Burden of Brain Metastasis in an Metastatic Non-Small Cell Lung Cancer (NSCLC) PopulationGanguli, A. / Henk, H. / Teitelbaum, A. / Ray, S. et al. | 2011
- A442
-
PCN50 First and Second Line Lung Cancer Treatment Utilization Patterns and associated Costs in A United States Health Care Claims DatabaseRamsey, S. / Henk, H. / Sullivan, J. / Teitelbaum, A. / Akhras, K. / Sollano, J. / Smith, G. / Chen, C. et al. | 2011
- A443
-
PCN55 The Economic Burden of Adjuvant Chemotherapy in GermanyEiermann, W. / Rezai, M. / Kuemmel, S. / Kü / hn, T. / Benkow, A. / Hogberg, D. / Schweikert, B. / Blohmer, J. U. et al. | 2011
- A444
-
PCN60 Economic Evaluation of Vaccination Against Cervical Cancer in the Moscow RegionShakhanina, I. / Namazova-baranova, L. / Krasnopolskiy, V. I. / Zarochentseva, N. V. / Kozachenko, V. P. / Demarteau, N. / Shchurov, D. et al. | 2011
- A445
-
PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in CanadaCasciano, R. / Chulikavit, M. / El Ouagari, K. / Wang, X. et al. | 2011
- A446
-
PCN70 Cost-Effectiveness of Cetuximab and Bevacizumab in the First-Line Treatment of Metastatic Colorectal Cancer (mCRC) for Patients with Kras Wild-Type Tumours in the United KingdomSamyshkin, Y. / Hertel, N. / Griebsch, I. et al. | 2011
- A447
-
PCN75 Epidemiologic and Economic Impact of HPV (6/11/16/18) Vaccination in TurkeyBakir, M. / Levent, A. / Nagy, L. / Brandtmü / ller, A. / Singhal, P. / Pillsbury, M. / Dasbach, E. et al. | 2011
- A448
-
PCN80 Comparative Analysis of Cost-Effectiveness Bevacizumab + Paclitaxel Versus Using Only Versus Paclitaxel as First Line Treatment of Patients with Metastatic Breast Cancer in Mexico Public Insurance (Seguro Popular)Arreola Ornelas, H. / Rosado Buzzo, A. / Garcí / a, L. / Camacho, L. M. / Lechuga, D. et al. | 2011
- A449
-
PCN86 Cost-Effectiveness of Rituximab in Follicular Lymphoma First Line Maintenance Treatment from Public Payer Perspective in PolandGadaj, A. / Kalinowska, A. / Hawrylecka, D. / Holojda, J. / Krawcewicz, A. / Spychalowicz, W. / Russel-Szymczyk, M. / Szkultecka-debek, M. et al. | 2011
- A450
-
PCN91 Pharmacoeconomic Analysis of mCRC Therapy With XELOX/FOLFOX4 Regimes With Bevacizumab or Cetuximab as the First Line Treatment in RussiaTikhomirova, A. V. / Yagudina, R. I. / Kulikov, A. U. et al. | 2011
- A452
-
PCN102 Economic Evaluation of Three Formulations of Leuprolide Acetate With Atrigel® in Androgen Deprivation Therapy for Advanced Prostate Cancer in Nine European CountriesRetsa, P. / Sidhu, M. / Odeyemi, I. / Tombal, B. / Wex, J. et al. | 2011
- A453
-
PCN107 Potential Benefits of Introducing A Companion Diagnostic in Advanced Non-Small Cell Lung CancerZaim, R. / Gaultney, J. / Redekop, W. / Uyl-de Groot, C. et al. | 2011
- A455
-
PCN117 Health Resource Utilisation (HRU) Associated with Skeletal-Related Events (SREs) in Patients with Bone Metastases (BMS): Results From a Retrospective, Multinational European StudyGunther, O. / Body, J. J. / Sleeboom, H. / Hechmati, G. / Pereira, J. / Maniadakis, N. / Terpos, E. / Acklin, Y. P. / Finek, J. / Mossman, T. et al. | 2011
- A456
-
PCN122 Disclosing Traditional & Complementary Medicines (T&CM) Use to the Health Care Providers: A Qualitative Study Among Cancer Patients at a Local Hospital in MalaysiaFarooqui, M. / Hassali, A. / Knight, A. / Akmal, A. / Tan, B. S. / Farooqui, M. A. et al. | 2011
- A457
-
PCN128 EQ-5D Utility Index in Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) With Progression During or After First-Line Docetaxel TherapyJames, N. / Eisenberger, M. / Fizazi, K. / Heidenreich, A. / Joulain, F. / Laizet, C. et al. | 2011
- A458
-
PCN133 Measuring Patients' Expectation and Satisfaction With Integrative Cancer TherapyAn, S. M. / Kim, S. H. / Kim, K. S. / Chung, H. S. / Lee, S. K. / Cheon, S. / Lee, S. H. / Park, S. / Kim, E. H. / Eo, W. K. et al. | 2011
- A459
-
PCN138 The Impact of Advanced or Metastasic Non-Small Cell Lung Cancer (NSCLC) Symptoms on Patient Daily Living and Health Related Quality of Life: Final ResultsArtal, A. / Oramas, J. / Cobo, M. / Domine, M. / Barneto, I. / Rodrí / guez-Abreu, D. / Menendez-ureñ / a, M. / Andrade, J. et al. | 2011
- A461
-
PCN148 Estimating Quality of Life in Advanced Melanoma; A Comparison of Standard Gamble, SF-36 Mapped, and Eortc QLQ-C30 Mapped UtilitiesBatty, A. J. / Fisher, D. / Winn, B. / Wang, Q. / Tolley, K. / Rowen, D. et al. | 2011
- A462
-
PCN154 Discussing the Introduction of National Screening Programs in Greece: A Delphi StudySkroumpelos, A. / Pavi, E. / Kyriopoulos, J. et al. | 2011
- A463
-
PCN159 Diagnostics and Treatment of Patients with Non-Small-Cell Lung Cancer in Daily PracticeBlommestein, H. / Groen, H. / Smit, E. / Thunnissen, E. / Uyl-de Groot, C. et al. | 2011
- A464
-
PCN165 A First Estimate of the Incremental Impact of Males HPV Vaccination on HPV-Related Diseases in EuropeBresse, X. / Largeron, N. / Marty, R. / Roze, S. et al. | 2011
- A465
-
PCN171 Underlying Causes for Sub-Optimal Utilisation of Cancer Drugs Funds in EnglandViejo Viejo, I. / Kilby, S. et al. | 2011
- A466
-
PCN177 Assessment of Reimbursement Processes and Outcomes for Cancer Drugs in Croatia – Comparison to NICE and NCCN GuidelinesVitezic, D. / Vrdoljak, E. / Bolanca, S. et al. | 2011
- A467
-
PCN183 A Population-Based Registry for the Evaluation of New Treatment Options for Patients with Metastatic Renal Cell CarcinomaDe groot, S. / Redekop, W. / Kiemeney, L. / Uyl-de Groot, C. et al. | 2011
- A468
-
PCN188 Did Decision-Making Models from National Guidelines Change 1st Line Treatment Strategy for Patients with Metastatic Colorectal Cancer (MCRC)? The Results of Large Population Based Survey in Germany 2009Kellermann, L. / Hofheinz, R. D. / Arnold, D. et al. | 2011
- A469
-
PCN193 Using Whole Disease Modelling to Inform Economic Recommendations for the Detection, Diagnosis, Treatment and Follow-up of Colorectal CancerTappenden, P. / Brennan, A. / Chilcott, J. / Squires, H. et al. | 2011
- A471
-
PDB2 Considerably Increasing Incidence of Severe Hypoglycemia 2007-2010 Versus 1997-2000 – a German Longitudinal Population-Based StudyHolstein, A. / Patzer, O. M. / Machalke, K. / Holstein, J. D. / Dippel, F. W. / Kovacs, P. et al. | 2011
- A472
-
PDB8 A Network Meta Analysis to Compare Glycaemic Control in Patients with Type 2 Diabetes Treated with Exenatide Once Weekly or LiraglutideScott, D. / Boye, K. S. / Timlin, L. / Best, J. H. / Clark, J. et al. | 2011
- A473
-
PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on Basal Insulin and/or Other Anti-Diabetic Treatment (API Registry)Gottesman, I. / Girard, M. / Shorey, S. et al. | 2011
- A474
-
PDB18 Australia: Management of the Diabetic Foot with Pedimed® Under Real Use ConditionsTaieb, C. / Auges, M. et al. | 2011
- A475
-
PDB24 Budget Impact Analysis of the Use of Aspart Insulin During Hospitalization of Patients with Hyperglycaemia in ItalyIannazzo, S. / Pradelli, L. / Montagnoli, R. / Militano, L. et al. | 2011
- A476
-
PDB29 Modeling the Impact of Enhanced Treatment of Type 2 Diabetes Mellitus in BulgariaBoyanov, M. / Petrova, G. / Henriksen, O. / Valov, V. et al. | 2011
- A477
-
PDB35 Estimating the Real Life Daily Usage and Daily Cost of GLP-1 Receptor Agonists in the UK SettingMcDonell, A. / Zammit, D. C. / Haslam, T. / Gregor, Z. / Wilson, B. P. et al. | 2011
- A478
-
PDB40 Economic Analysis of Diabetes Treatment Goals Defined by Polish Diabetes Association: How Much Does Cost-Effective Treatment Cost?Szmurlo, D. / Schubert, A. / Kostrzewska, K. / Rys, P. / Skrzekowska-Baran, I. et al. | 2011
- A479
-
PDB45 Cost-Effectiveness of Transferring Type 2 Diabetic Patients from Neutral Protamine Hagedorn (NPH) to Detemir in Portugal SettingsCarvalho, D. / Lindner, L. / Kozarzewski, M. et al. | 2011
- A480
-
PDB50 Reduction in Comorbidities and Cost Savings Associated with Biochemical Control in Patients with Cushing's Disease: A Literature-Based AnalysisPatel, D. / Stephens, J. M. / Wiegand, P. / Pulgar, S. et al. | 2011
- A482
-
PDB61 Assessment of Quality of Life in Children and Adolescents with Type 1 Diabetes MellitusMoreira, S. / Almeida, A. / Guerra, P. et al. | 2011
- A483
-
PDB66 Achievement of Glycemic Control and Relapse Among Patients Initiating Basal Insulin from a Geographically-Diverse Us Electronic Medical Record (EMR) DatabaseAargen, M. / Wu, N. / Boulanger, L. / Lamothe, K. et al. | 2011
- A484
-
PDB71 Cross-Sectional Analysis of Ambulatory Care Expenditure Among Patients with Type 2 Diabetes Mellitus (T2DM) According to Treatment Stage and Renal Function in France Using EGB Database (Echantillon Generaliste De Beneficiaires)Guelfucci, F. / Clay, E. / Aballea, S. / Toumi, M. / Lassalle, R. et al. | 2011
- A485
-
PDB77 Impact of Knowledge on Medication Adherence Among Type 2 Diabetes PatientsAl-Qazaz, H. K. / Syed Sulaiman, S. A. / Hassali, M. A. / Shafie, A. A. / Sundram, S. / Saleem, F. et al. | 2011
- A486
-
PDB82 Development of a Health Economic Model to Compare the Prevention, Treatment and Management Strategies of Type 2 DiabetesNagy, B. / Nagyjanosi, L. / Nagyistok, S. / Jó / zwiak-Hagymá / sy, J. / Dessewffy, Z. / Kalo, Z. / Vokó / Z. et al. | 2011
- A487
-
PRS4 Effectiveness Of a Multifactorial Intervention to Improve Adherence in Patients with Chronic Obstructive Pulmonary Disease (COPD) Icepoc StudyLeiva-Fernandez, F. / Barnestein-Fonseca, P. / Leiva- Fernandez, J. / Vidal-Españ / a, F. / Garcí / a-Ruiz, A. / Prados-Torres, D. et al. | 2011
- A488
-
PRS10 A Comparative Health Economic Evaluation of Two Treatments for Grass Pollen Induced Allergic RhinoconjunctivitisRonborg, S. M. / Svendsen, U. G. / Micheelsen, J. S. / Ytte, L. / Andreasen, J. N. / Ehlers, L. et al. | 2011
- A489
-
PRS15 Estimating the Budget Impact of Introducing Indacaterol in the Treatment of Chronic Obstructive Pulmonary Disease (COPD) from the Brazilian Public Health Care System (SUS) PerspectiveSuzuki, C. / Silva, N. L. et al. | 2011
- A490
-
PRS20 Costs of COPD By Disease Severity - a Comparison Over 10 YearsJansson, S. A. / Backman, H. / Lindberg, A. / Rö / nmark, E. / Lundbä / ck, B. et al. | 2011
- A492
-
PRS30 Identifying the Patient Population Where Treatment of Severe Allergic Asthma with Omalizumab (XOLAIR®) Exhibits Optimal Cost-Effectiveness in AustraliaTilden, D. / Cottrell, S. / Tocchini, L. / Frenzel, C. / Bonney, M. A. et al. | 2011
- A493
-
PRS36 The Cost-Effectiveness of Step Down from High Dose ICS/Laba Combination Therapy in Asthma in the UK SettingPaggiaro, P. / Buseghin, G. / Nicolini, G. / Patel, S. / Iannazzo, S. / Zaniolo, O. / Papi, A. et al. | 2011
- A494
-
PRS41 Cost-Effectiveness Analysis of Immunotherapy in Patients with Grass Pollen Allergic RhinitisWesterhout, K. Y. / Verheggen, B. G. / Schreder, C. H. / Sieber, J. / Augustin, M. et al. | 2011
- A495
-
PRS46 Effectiveness and Cost-Utility Estimates of Tiotropium Treatment and Pulmonary Rehabilitation Programs in French Patients with Chronic Obstructive Pulomonary DiseaseAtsou, K. / Hejblum, G. / Chouaid, C. et al. | 2011
- A496
-
PRS51 The Development of the Early Morning Symptoms of COPD Instrument (EMSCI)Palsgrove, A. / Houghton, K. / Hareendran, A. / Schaefer, M. / Setyawan, J. / Mocarski, M. / Carson, R. / Make, B. et al. | 2011
- A497
-
PRS56 Assessing Patient Report of Function: Content Validity of the Functional Performance Inventory-Short form (FPI-SF) in Patients with Chronic Obstructive Pulmonary DiseaseLeidy, N. / McCormack, J. / Hamilton, A. / Becker, K. et al. | 2011
- A498
-
PRS62 Comparison of Generic and Disease Specific Quality of Life Measures in Chronic Obstructive Pulmonary DiseaseAgh, T. / Inotai, A. / Meszaros, A. et al. | 2011
- A499
-
PRS67 Consumption Patterns and in Vitro Resistance of S. Pneumoniae to FluoroquinolonesSimoens, S. / Verhaegen, J. / Van Bleyenbergh, P. / Peetermans, W. / Decramer, M. et al. | 2011
- A500
-
PRS72 How Much Would the Universal Uptake of Gold Recommendations for Italian COPD Patients Cost?Zaniolo, O. / Bettoncelli, G. / Bosio, G. / Mantovani, L. G. / Pistelli, R. / Vaghi, A. / Villa, M. / Iannazzo, S. / Bamfi, F. / Pitrelli, A. et al. | 2011
- A501
-
PRS77 Application of Innovative Methods to Identify and Characterize Differential Responders in Clinical Trials of COPD: The Use of Mixture ModelsStull, D. E. / Houghton, K. / Gale, R. / Wiklund, I. / Capkun-Niggli, G. / Jones, P. et al. | 2011
- A502
-
PSS5 Visual Field Evolution in Glaucoma Patients Presenting With Different Disease Stages: Results From an Observational StudyGerlier, L. / Shlaen, R. / Wolfram, C. / Lamotte, M. / Verboven, Y. et al. | 2011
- A503
-
PSS11 Ranibizumab and Bevacizumab for the Treatment of Age-related Macular Degeneration: A Systematic Review and Economic EvaluationMartinez Ferez, I. M. / Flores Moreno, S. et al. | 2011
- A504
-
PSS16 Cost of Blindness in AustriaBrennig, C. / Schö / llbauer, V. / Walter, E. et al. | 2011
- A505
-
PSS22 A Cost-Effectiveness Analysis of Off-Label Biologics to Treat Sarcoid Posterior Uveitis Versus Standard of Care: Comparing Infliximab to Methotrexate and Systemic SteroidsPadula, W. V. / Yilmaz, T. / Cordero-Coma, M. et al. | 2011
- A506
-
PSS27 We Treat Eyes, Not People: The Systematic Overestimations of Utility in Age-Related Macular Degeneration ModelsVisser, M. S. / Amarakoon, S. / Missotten, T. / Busschbach, J. et al. | 2011
- A507
-
PSS32 Impact of Dry Eye on Everyday Life (Ideel) - Symptom Bother: Estimating Cut-off Scores for Dry Eye Severity GroupsAcaster, S. / Verboven, Y. / Begley, C. / Chalmers, R. / Abetz, L. / Thompson, T. et al. | 2011
- A508
-
PSS37 the Clinical and Economic Burden of Acute Otitis Media: A Large Prospective Observational Cohort Study in EuropeLiese, J. G. / Giaquinto, C. / Silfverdal, S. A. / Carmona, A. / Larcombe, J. / Garcia-Sicilia, J. / Fuat, A. / Muñ / oz Hiraldo, E. / Arroba Basanta, M. L. et al. | 2011
- A509
-
PSS42 Evaluation of the Impact of Writing Exercises and Educational Interventions on Quality of Life in Patients With PsoriasisTabolli, S. / Pagliarello, C. / Sampogna, F. / Di Pietro, C. / Abeni, D. / Centro Studi GISED, I. et al. | 2011
- A511
-
ISPOR 14th annual European congress financial disclosure information for research presetnations| 2011
- A521
-
ISPOR 14th Annual European Congress Research Abstracts Author Index| 2011
- A535
-
EX2 Health Care Resource Use Among Patients With Bipolar Disorder From Brazil and Venezuela: Subgroup Analysis of Data From A Large Multinational Longitudinal Study (WAVE-BD Study)Vieta, E. / Baptista, T. / Bifano, M. / Kerr-Corrê / a, F. / Grohs, G. / de Oliveira, I. / Vielma, X. / Montes, C. / Beluche, S. et al. | 2011
- A536
-
QA3 Costo-Efectividad De Dabigatran Versus Warfarina En El Manejo De La Fibrilacion Auricular En ColombiaAlfonso-Cristancho, R. / Herran, S. / Caicedo, M. / Gomez, E. et al. | 2011
- A537
-
VA1 Evaluacion Rápida Del Impacto De La Introduccion De La Vacuna Contra El Rotavirus En ColombiaRico Mendoza, F. A. / Porras, A. / Alvis, N. / De La Hoz, F. / Cediel, N. / Del Rio, F. et al. | 2011
- A538
-
CN2 Cancer De Pulmon Y Tabaco, Analisis Del Costo De Atencion MedicaQuintana Carrillo, R. / Arrieta Rodrí / guez, O. / Zinser Sierra, J. / Correa Acevedo, M. / Mohar Betancurt, A. / Reynales Shigematsu, L. et al. | 2011
- A539
-
HS3 The Economic Burden of Road Traffic Injuries on Health System and Society in BelizeHeredia Pi, I. B. / Pé / rez Nú / ez, R. / Hijar Medina, M. / Jones, S. / Silveira Rodrigues, E. M. et al. | 2011
- A540
-
IN4 Morbidity and Mortality of Community Acquired Pneumonia in Adults in Six Countries in Latin AmericaRosado-Buzzo, A. / Garcia-Mollinedo, L. / Camacho-Cordero, L. / Roberts, C. S. / Mould-Quevedo, J. F. / Trejo-Martinez, A. / Luna-Casas, G. et al. | 2011
- A541
-
RM2 Aplicacion de Modelos De Regresion Con Stata Para El Estudio Del Consumo de Recursos En Unidades De Cuidados Intensivos NeonatalesReyes-Lopez, A. et al. | 2011
- A542
-
PCN3 Estimacion De La Carga De Los Tumores Neuroendocrinos En ColombiaRuiz, A. / Alfonso-Cristancho, R. / Mejia, A. / Gonzalez, D. / Maestre, K. / Herran, S. et al. | 2011
- A543
-
PCN8 Cost-Effectiveness Analysis of an Opioid in Combination with Gabapentin Versus Monotherapy for the Treatment of Neuropathic PainGalindo, L. / Guajardo, J. / Plancarte, R. / Cerezo, O. / Najera, E. / Gonzalez, I. et al. | 2011
- A544
-
PCV4 Analisis Costo Efectividad En El Largo Plazo De Los Stents Liberadores De Farmaco vs Stents Convencionales En Pacientes Con Cardiopatia Isquemica En El ImssGonzalez-Diaz, B. E. / Salinas Escudero, G. / Granados-Garcia, V. / Herná / ndez, I. C. / Abbo, M. C. et al. | 2011
- A545
-
PCV9 Costo–efectividad De Los Ácidos Grasos Omega 3 Como Coadyuvante De La Simvastatina En El Tratamiento De La HipertrigliceridemiaRendon, D. / Ordoñ / ez, J. / Orozco, J. J. et al. | 2011
- A546
-
PDB5 Use of a Discrete Event Simulation Model to Estimate Clinical and Economic Outcomes of Various Self-Monitoring of Blood Glucose Regimes Plus Conventional Pharmacologic Treatment on Type-2 Diabetic Patients in MexicoZanela, O. O. / Cabra, H. A. / Muñ / oz, D. F. et al. | 2011
- A547
-
PDB10 Economic Evaluation of Duloxetine as First-Line Treatment for Painful Diabetic peripheral Neuropathy in MexicoCarlos, F. / Ramí / rez-Gá / mez, J. / Dueñ / as-Tentori, H. / Ramos, E. et al. | 2011
- A548
-
PGI4 Health-Related Quality of Life Improvements in Patients with Active Crohn's Disease Following Treatment with Certolizumab Pegol in the Music Study (NCT00297648)Hé / buterne, X. / Lé / mann, M. / Coteur, G. / Ernault, E. / Colombel, J. F. et al. | 2011
- A549
-
PHP6 Cuadro Básico Y CatÁlogo De Medicamentos Del Sector Salud: Es Actualmente Un referente Para Las instituciones PÚblicas Y/O cumple Con Los Objetivos De Su CreaciónRivera-Peñ / a, G. / Vargas-Palacios, A. / Barraza-Llorens, M. / Gutierrez-Delgado, C. et al. | 2011
- A551
-
PHP18 Impacto De La Participacion Del Farmaceutico Como Parte Del Equipo De Salud En El Primer Nivel De atencion sobre Los CostosMino-Leon, D. / Contreras-Hernandez, I. / Anaya, P. / Reyes, A. et al. | 2011
- A552
-
PHP24 ComparaÇÃo Da qualidade De Vida Entre Pessoas Com DoenÇas Crónicas E Pessoas Da Comunidade Sem DoenÇaPais-Ribeiro, J. / Silva, I. / Pedro, L. / Meneses, R. / Cardoso, H. / Abreu, M. / Melo, V. / Martins, A. / Martins-da Silva, A. / Vilhena, E. et al. | 2011
- A553
-
PHP29 Predictors of Appropriate Use of Insecticide Treated Nets in an Urban Community: The Case of Asokwa Sub-Metropolitan Area, Kumasi, Ashanti, GhanaAgyei-Baffour, P. / Mantey, K. G. / Owusu-Dabo, E. et al. | 2011
- A554
-
PHP36 Historical and Future Drivers for HTA in Reimbursement Systems in Mexico and PolandKirpekar, S. / Shankland, B. et al. | 2011
- A555
-
PHP41 Monitoring of HPV Vaccination Effectiveness Within European UnionBielik, J. / Maruš / ková / E. / Glogowski, C. et al. | 2011
- A556
-
PHP47 AvaliaÇÃo Do Mercado De Antimicrobianos No Brasil: Passo Para ImplantaÇÃo Do Monitoramento E Controle SanitÁrio Em Estabelecimentos FarmacÊuticosMota, D. M. / Araú / jo, M. A. / Santos, A. E. / Cunha, T. R. / Silva, S. F. / Bovi, R. F. / Alaver, R. T. / Albo, G. C. / Cunha, J. A. et al. | 2011
- A558
-
PIN2 Facing Critical Health Events: Economic Impact Of AH1N1 Flu Epidemic In The Mexican Health Sector, 2009-2010Gutierrez-Delgado, C. / Gó / mez-Fraga, S. et al. | 2011
- A559
-
PIN8 Evaluacion Economica De La Extension De Profilaxis Contra CMV De 100 A 200 Dias En Receptores De Trasplante Renal Con Alto Riesgo (D+ / R−)Morales Buenrostro, L. E. et al. | 2011
- A560
-
PMH2 The COST-Effectiveness Of Paliperidone Palmitate Compared To Olanzapine Pamoate In The Treatment Of Schizophrenia In SwedenPudas, H. / Hemels, M. / Mehnert, A. / Druais, S. / Martin, M. et al. | 2011
- A561
-
PMS3 Impacto Economico De La Osteoporosis Y De Las Fracturas Por Fragilidad En El instituto Mexicano Del Seguro socialClark, P. / Carlos, F. / Chico, G. / Galindo-Suarez, R. M. et al. | 2011
- A562
-
PMS8 Cost-Effectiveness analysis of Etanercept versus Available anti-Tnf and Il-6 Blockers for Treating Rheumatoid Arthritis in GuatemalaLutz, M. / Cuesta, G. / Morales, G. et al. | 2011
- A563
-
PMS13 Economic Model of Workplace Impacts of anti-Tnf therapy for Rheumatoid Arthritis in BrazilTeich, V. / Chaves, L. / Birnbaum, H. / Pike, C. / Waryas, C. / Cifaldi, M. et al. | 2011
- A565
-
PRS4 Economic Evaluation of the Use of Palivizumab as prophylactic Treatment for the reduction of Complications associated with respiratory Syncytial Virus in Pre-Term PatientsMayen-Herrera, E. / Buesch, K. / Cortina, D. et al. | 2011
- A566
-
PRS9 Disponibilidad A Pagar Por Un Metodo Efectivo Para Dejar De Fumar: Evidencias A Partir De La Encuesta Global De Tabaquismo En Adultos MÉxico 2009Heredia, I. / Servá / n, E. / Reynales, L. M. / Bautista, S. et al. | 2011
- A567
-
PSY2 ESTIMACIÓn Del Impacto Financiero En La Salud De La POBLACIÓn Mexicana Derivado De La Obesidad Y El Sobrepeso, 2000-2017Guajardo-Barron, V. J. / Gutierrez-Delgado, M. C. et al. | 2011
- A568
-
PSY7 Cost Of Managing Bleeding-Related Episodes (BRE) For Romiplostim Versus Standard Of Care (SOC) In Patients With Chronic Immune Thrombocytopenia (ITP) In MexicoArocho, R. / Northridge, K. / Rivera Hurtado, R. / Chavez, J. G. et al. | 2011
- A569
-
PUK1 Comparison Of Direct Medical Cost Of Dialysis In A Mexican Cohort Either On Peritoneal Or HemodialysisMayen-Herrera, E. / Cortes, M. / Marx, S. E. / Sterz, R. et al. | 2011
- A571
-
ISPOR 3rd Latin America conference disclosure information for reserch presentations| 2011
- A573
-
ISPOR 3rd Latin America Conference Research Abstracts Author Index| 2011
- i
-
Table of Contents| 2011
- I
-
Instructions for Authors| 2011
-
PRM3 Challenges to Obtain Real-Life Data in Observational Studies: What are the Solutions When the Patient is the Main Data Provider?El kebir, S. / Bourhis, Y. / Fournie, X. et al. | 2011
-
PRM24 Scan: An Integrated System for Market Access of New Drugs in ItalyLanati, E. P. / Lidonnici, D. / D'Ausilio, A. / Iorio, A. / Jommi, C. et al. | 2011
-
PRM39 Identification of Diseases for EQ-5D Bolt-on Item Development: An Empirical ApproachSolem, C. T. / Gu, N. Y. / Pickard, A. S. et al. | 2011
-
PRM42 Valuation of HR-QoL Utilities by the EQ-5D in a Group of Chronically Ill PatientsVanhaute, O. A. / Peleman, R. / Annemans, L. et al. | 2011
-
PRM43 Direct from the Patients – Research Into What Patients Would Like to Improve in Their Electronic Diary ExperienceO'Gorman, H. J. / Ross, J. et al. | 2011
-
PRM46 Linguistic Validation and ePRO – Value of CollaborationZarzar, K. M. / Dawsey, R. et al. | 2011
-
PRM50 Sample Size and Ethical Considerations in Randomized Cluster Sampling Versus Individual Patient Recruitment Formulas in Prospective Observational StudiesChiappinelli, R. / Stanley, S. / Criscola, R. / Wasser, T. et al. | 2011
-
PRM54 Model and Covariate Visualization Aids for Enhancing the Interpretation of Steps in the High Dimensional Propensity Scoring Adjustment ProcedureJuneau, P. / Huse, D. M. et al. | 2011
-
PRM65 Should We Aggregate Cost-Effectiveness over an Intervention's Entire Implementation Lifetime?O'Mahony, J. et al. | 2011
-
PCN10 Comorbid Cardiovascular Diseases in Patients with Metastatic Colorectal CancerOverbeek, J. A. / Zhao, Z. / van Herk-Sukel, M. P. / Barber, B. / Gao, S. K. / Herings, R. M. et al. | 2011
-
PCN62 Costs and Consequences of HPV Vaccination in Thailand: Results of a Prevalence Based ModelVan Enckevort, P. / Kongngamkam, K. / Van Kriekinge, G. et al. | 2011
-
PCN89 Public Health Impact of Quadrivalent HPV Types 6, 11, 16, 18 Vaccine in Sao Paulo, Brazil Using A Transmission Dynamic ModelSinghal, P. / Tannus, G. / Pillsbury, M. / Dasbach, E. et al. | 2011
-
PCN111 Cost-Effectiveness of Human Papillomavirus Vaccination for Prevention of Cervical Cancer in Roraima, A Brazilian Amazonic Region StateBalbinotto, G. / Jardim, A. et al. | 2011
-
PCN131 Systematic Evaluation of Specific Quality of Life Instruments for Prostate CancerSchmidt, S. / Pardo, Y. / Vilagut, G. / Garin, O. / Pont, A. / Cunillera, O. / Becerra, V. / Ferrer, M. et al. | 2011
-
PCN135 Influence of Economic Implications Related to the Prescription of Oral and Intravenous Chemotherapy on Physicians' Preferences: A Discrete Choice ExperimentBenjamin, L. / Cotté / F. E. / Philippe, C. / Mercier, F. / Bachelot, T. / Vidal-Tré / can, G. et al. | 2011
-
PCN147 Health-Related Quality of Life in Head and Neck Cancer Patients - Comparison with General Population NormsLahtiharju, T. / Mä / kitie, A. A. / Saarilahti, K. / Bä / ck, L. / Rä / sä / nen, P. / Sintonen, H. et al. | 2011
-
PCN150 Willingness to Pay for A Reduction in Risk of Treatment Side Effects in Patients with Metastatic Breast CancerLalla, D. / Mclaughlin, T. / Brammer, M. / Bramley, T. / Bare, A. / Carlton, R. et al. | 2011
-
PCN160 Prostate Cancer Screening Practices in the Republic of Ireland- The Determinants of UptakeBurns, R. / Walsh, B. / Sharp, L. / O'Neill, C. et al. | 2011
-
PCN176 Cancer Drug Prices in the United States and the United Kingdom: Implications for Pricing Strategy and Drug AccessAggarwal, S. et al. | 2011
-
PCN179 Clinical Trials in Oncology in GreeceMylona, K. / Kyriopoulos, J. et al. | 2011
-
PDB12 Glargine Utilisation in Russia: A Prospective Study to Evaluate Patients Switched from NPH Insulin to Insulin Glargine Compared with Those Maintained on NPHSkudaev, S. / Verbovaya, N. et al. | 2011
-
PDB15 Use of Hypoglicemic Drugs in Serbia: Pharmacotherapeutic Versus Pharmacoeconomic AspectsSabo, A. / Tomic, Z. et al. | 2011
-
PDB44 An Economic Evaluation of the Use of Pioglitazone in Italy Using ProactiveGladwell, D. / Capri, S. / Fionda, A. / Massi-Beneddeti, M. et al. | 2011
-
PDB52 Adherence with Oral Medications for Diabetes Among Brazilian Patients: A Systematic Review of National LiteratureTakemoto, M. L. / Fernandes, R. A. / Tolentino, A. C. / Takemoto, M. M. / Cukier, F. N. / Cruz, R. B. / Santos, P. M. / Ribeiro, A. C. / Fernandes, R. R. / Moretti, A. I. et al. | 2011
-
PDB59 Nocturnal Hypoglycemic Events: Impacts on Patients Functioing, Well-Being and Diabetes ManagementBrod, M. / Wolden, M. / Pohlman, B. / Christensen, T. et al. | 2011
-
PRS21 Resource Utilization and Associated Costs of Community Acquired Pneumonia (CAP) in Adults: Observational Study in a Population Setting in a Well Defined Area of Barcelona (Badalona, Spain)Sicras-Mainar, A. / Guijarro, P. / de Salas-Cansado, M. / Cifuentes-Otero, I. / Navarro-Artieda, R. et al. | 2011
-
PRS23 High Cost Cystic Fibrosis Patients as Identified in a Us Claims Database: A Closer Look at the TailHarrow, B. / Becker, C. C. / Buikema, A. et al. | 2011
-
PRS27 Trends in Uk Smoking Cessation Prescription Expenditure Over Time - a Thin Database StudyBlak, B. T. / Lee, J. / Dungarwalla, M. et al. | 2011
-
PRS59 Quality of Life in Severe Persistent Uncontrolled Asthma: Patients and Caregivers in the Spanish Pediatric Population: A Prex StudyGalera, J. / Lahoz, R. / Herrá / ez, L. / Casafont, J. / Plaza, A. / Vennera, M. et al. | 2011
-
PRS68 A Systematic Review of Chronic Rhinosinusitis in Asia-Pacfic and the Role of Balloon SinuplastyMcElroy, H. J. / Belarbi, S. / Foteff, C. / Metz, L. / Chung, L. / Levine, H. L. / O' / Leary, B. A. et al. | 2011
-
PSS10 Economic Outcomes of Glaucoma Treatment With Prostaglandin Eye Drops Preserved With Polyquad® Instead of Benzalkonium Chloride in GermanyGerlier, L. / Lamotte, M. / Lorenz, K. / Berdeaux, G. / Verboven, Y. / Pfeiffer, N. et al. | 2011
-
PSS13 Economic Burden of Psoriasis and Diabetes in Patients With Psoriasis in the United StatesGuerin, A. / Latremouille-Viau, D. / Day, R. / Khan, Z. / Zhang, F. et al. | 2011
-
PSS18 Direct Economic Burden of Regular Intravitreal Injections for the Treatment of Retina Diseases in Three European CountriesJohnson, M. K. / Lara, N. et al. | 2011
-
QA2 Analisis De Costo-Utilidad De Rituximab Posterior Al Fallo Por Anti-Tnf En Artritis Reumatoide Para ColombiaRomero, M. / Latorre, M. / Alvarado, C. / Karpf, E. / Alvis, N. et al. | 2011
-
HS2 Analisis De Costos Del Programa Ampliado De Inmunizaciones En Colombia 2009Romero, M. / Arango, C. / Chavez, D. / Otero, J. / Alvis, N. et al. | 2011
-
PDB7 Cost-Effectiveness of Saxagliptin Treatment in Three Latin American CountriesElgart, J. F. / Caporale, J. E. / Aiello, E. C. / Waschbusch, M. / Jotimliansky, L. / Gagliardino, J. J. et al. | 2011
-
PGI3 AdaptaciÓn De Un ANÁlisis De Costo-Efectividad Del Entecavir vs InterferÓn Pegilado Alfa a VenezuelaOrozco, J. J. / Valencia, J. E. / Aiello, E. / Baquero, E. et al. | 2011
-
PIH4 Analisis De Costo-Efectividad Del Uso De Levonorgestrel-Uis Frente A Otros Tratamientos En Menorragia IdiopaticaRomero, M. / Arango, C. / Espinel, F. / Karpf, E. / Sanabria, M. / Alvis, N. et al. | 2011
-
PIN6 Evaluacion COSTO-Efectividad Del Uso De Linezolid En El Tratamiento De Neumonias Nosocomiales En MÉXICOVargas-Valencia, J. J. / Sotelo-Guzmá / n, M. / Dí / az-Ponce, H. / Galindo-Suá / rez, R. M. / Muciñ / o-Ortega, E. / Mould-Quevedo, J. F. et al. | 2011
-
PMS10 Cost-Effectiveness of Duloxetine Compared to Pregabaline in Patients with Fibromyalgia from the Public Health Care System perspective in MéxicoRamí / rez-Gá / mez, J. / Dueñ / as-Tentori, H. et al. | 2011
-
PMS11 review of the Studies on Economic Evaluation of Treatment for Postmenopausal OsteoporosisBrandã / o, C. M. / Acurcio, F. D. et al. | 2011
-
PMS12 Evaluacion Economica De Rituximab versus anti-Tnf En Pacientes Con Artritis reumatoide Y Falla Previa A anti-Tnf En MéxicoCarlos, F. / Clark, P. et al. | 2011
-
PSS1 Evaluacion Economica De Fototerapia De Banda Angosta O Fotoquimioterapia Para El Tratamiento De Psoriasis Desde La Perspectiva Del Instituto Mexicano Del Seguro SOCIALCarlos, F. / Ramos, E. / Llorens, F. / Ruiz, L. et al. | 2011
-
PSY1 Epidemiology And Socioeconomic Burden Of Overweight And Obesity In ArgentinaElgart, J. F. / Gonzalez, L. / Caporale, J. E. / Pfirter, G. / Gagliardino, J. J. et al. | 2011
-
DA2 A Choice that Matters: Comparing Methods of Data Synthesis in Cost-Effectiveness ModellingVemer, P. / Al, M. / Oppe, M. / Rutten-Van Mö / lken, M. et al. | 2011
-
HT4 What Determines the Recommendations Issued by Polish Health Technology Agency (AHTAPol)?Niewada, M. / Polkowska, M. A. / Jakubczyk, M. / Golicki, D. et al. | 2011
-
MA4 Modelling EQ-5D Health State Values: Developing A Limited Dependent Variable, Mixture Modeling ApproachWailoo, A. J. / Herná / ndez, M. / Ara, R. et al. | 2011
-
RS4 The Interim Cancer Drugs Fund - How To Not Spend £50 MillionTimm, B. / Brooks-Rooney, C. / Hamerslag, L. / Costello, S. et al. | 2011
-
PMD19 Cost-Effectiveness of Implantable Defibrillators after Myocardial Infarction Based on 8-Year Follow-up Data (MADIT II)Gandjour, A. / Holler, A. / Adarkwah, C. C. et al. | 2011
-
PMD41 Drug Eluting Stent (DES) versus Bare Metal Stent (BMS) on Clinical, Humanistic and Economic outcomes: A 12-Month Prospective Observational StudyLee, V. / Yan, B. / Lau, J. C. / Tang, W. K. / Yu, C. M. et al. | 2011
-
PMD61 The Effects of Subjective Insomnia Pattern on the quality of Life of the Climacteric Women in TaiwanWu, H. C. / Lai, J. N. / Hwang, J. S. et al. | 2011
-
PMD62 Validation of A Patient-Reported Outcome (PRO) Measure and A Clinician-Reported Outcome (CRO) Measure to assess Satisfaction and Preference with Pharmacological Stress Agents for Single Photon Emission Computed tomography (SPECT) Myocardial Perfusion Imaging (MPI)Hudgens, S. / Kothari, S. et al. | 2011
-
PMD69 Treatment of Urinary Tract infections is Common amongst Swedish Patients in Need of Chronic CatheterisationBruce, S. / Lö / froth, E. / Knutsson, B. / Bö / rstell, T. / Myré / n, K. J. et al. | 2011
-
PSU24 Comparison of the Responsiveness of the SF-36 and the Raw and Rasch-Based Scores of the Oxford Knee Score in Patients Undergoing Total Knee ReplacementKo, Y. / Lo, N. N. / Yeo, S. J. / Yang, K. Y. / Chong, H. C. / Yeo, W. / Thumboo, J. et al. | 2011
-
PSU28 Economic Impact of Stereotactic Radiosurgery for Malignant Intracranial Brain TumorsLal, L. / Franzini, L. / Panchal, J. / Chang, E. / Meyers, C. A. / Swint, J. M. et al. | 2011
-
PIN5 Patient and Clinician Perceived Benefit of Early Consumption of Famciclovir for the Treatment of Herpes OutbreaksTwiss, J. / Mckenna, S. / Bloch, M. / Bonney, M. A. et al. | 2011
-
PIN14 Prescribing Patterns of Sebivo® (Telbivudine): A Survey Among Physicians in Selected European CountriesAponte torres, Z. / Lara, N. / Primatesta, P. / Trylesinski, A. et al. | 2011
-
PIN16 Rates and Predictors of Gonorrhea Re-Screening Among Privately Insured Patients with Gonorrhea in 2007-2009Shi, L. / Liu, J. / Kissinger, P. / Khan, M. / Wu, E. Q. et al. | 2011
-
PIN75 Cost-Effectiveness of Polysaccharide Pneumococcal Vaccination in People Aged 65 and Above in PolandGrzesiowski, P. / Soluch, S. / Adamczyk, K. / Durand, L. / Aguiar-Ibá / ez, R. / Martin, M. / Puig, P. E. et al. | 2011
-
PIN97 How Does Health-Related Quality of Life Relate to Symptoms Experience in HIV Patients Treated with Highly-Active Antiretroviral Therapy?Lalanne, C. / Armstrong, A. R. / Herrmann, S. / Chassany, O. / Duracinsky, M. et al. | 2011
-
PIN109 Modelling the Policy of Managing Seasonal Influenza in the UKVan Bellinghen, L. A. / Van Vlaenderen, I. / Meier, G. C. et al. | 2011
-
PMH22 Economic Burden of Attention Deficit Hyperactivity Disorder in Children and Adolescents in EuropeTaneja, A. / Ahuja, A. / Kataria, A. / Kaushik, P. / Kumar, P. et al. | 2011
-
PMH31 Cost-Effectiveness of Long-Acting Olanzapine Versus Long-Acting Risperidone in Patients with Schizophrenia in SpainDilla, T. / O'Donohoe, P. / Mö / ller, J. / lvarez, M. / Sacristá / n, J. / San, L. / Happich, M. / Tockhorn, A. et al. | 2011
-
PMH48 The Spanish Version of the Clinically Useful Depression Outcome Scale: A Valid Instrument to Evaluate Depressive Symptoms in Primary CareAgü / era, L. / Monton, C. / Medina, E. / Cuervo, J. / Rodrí / guez Aguilella, A. / Maurino, J. et al. | 2011
-
PMH50 Differences Between Opioid Dependent Patients in Italy and Germany Receiving Substitution TherapySevert, J. / Tkacz, J. / Ruetsch, C. et al. | 2011
-
PMH55 An Examination of Antidepressant-Related Sexual Dysfunction and Degree of Enjoyment and Satisfaction with Daily Activities, and Current Medication in Employed PatientsSchneider, G. / Roy, A. / Dabbous, O. H. et al. | 2011
-
PMH59 Employment Status and Self reported Quality of Life in Chinese Patients Receiving Treatment for Major Depressive DisorderXue, H. B. / Wu, S. H. / Brnabic, A. J. / Novick, D. / Kadziola, Z. / Granger, R. E. / Montgomery, W. et al. | 2011
-
PMH63 Stay Healthy Through Game-Care Therapeutics: It's Time to Play the Game!Aggarwal, A. et al. | 2011
-
PMH67 Drug Utilisation Adaptations in Sweden After the Effexor Patent ExpiryBruce, S. / Hjelmgren, J. / Lö / froth, E. / Myré / n, K. J. et al. | 2011
-
PMH72 The Impact of Once-Daily Extended-Release Quetiapine Fumarate (Quetiapine XR) on Length of Hospitalisation of Patients with Acute Bipolar ManiaBonafede, M. / Locklear, J. C. / Wahlqvist, P. / Fajutrao, L. / Szamosi, J. / Pan, K. / Eriksson, H. et al. | 2011
-
PMS4 Efficacy and Effectiveness of Collagenase Clostridium Histolyticum for Dupuytren'S ContractureSkodny, P. / Mackowiak, J. I. / Peimer, C. et al. | 2011
-
PMS17 The Effect of Biological Treatment on Work Productivity and Productivity Costs of Rheumatoid Arthritis PatientsKlimes, J. / Dolezal, T. / Vocelka, M. / Petrikova, A. / Kruntoradova, K. et al. | 2011
-
PMS26 Cost of Dupuytren Contracture in the Czech RepublicSkoupá / J. / Há / jek, P. et al. | 2011
-
PMS28 Retrospective Chart Review to Assess Utilization of Resources and Costs Related to Postmenopausal Osteoporotic Fractures in Slovenia, Serbia and BulgariaRutkowski, J. / Haldas, M. / Bolisega, D. / Jedynasty, K. / Kozlevcar Zivec, M. / Komadina, R. / Bumbasirevic, M. / Popivanov, P. et al. | 2011
-
PMS39 Economic Evaluation of Tocilizumab for the Treatment of Systemic Juvenile Idiopathic Arthritis in MexicoCarlos, F. / Clark, P. / Lechuga, D. et al. | 2011
-
PMS58 Pilot Validation of the Brief Fatigue Inventory ‘Fatigue at its Worst’ Item in Patients with Rheumatoid ArthritisNaegeli, A. N. / Sterling, K. L. et al. | 2011
-
PMS61 Rapid Reductions in Fatigue and Sleep Problems and Correlation with Improvements in Patient-Reported Outcomes in Patients with Active RA Treated with Certolizumab Pegol in the realistic 12-Week Phase IIIB Randomised Controlled StudyPope, J. / Fleischmann, R. / Dougados, M. / Bingham, C. O. / Massarotti, E. / Wollenhaupt, J. / Duncan, B. / Coteur, G. / Weinblatt, M. E. et al. | 2011
-
PMS60 Experiences of Patients with Rheumatoid Arthritis in the US and UK: A Cross-Cultural ComparisonSterling, K. L. / Bush, E. N. / Naegeli, A. / Swinburn, P. / Gallop, K. / Nixon, A. et al. | 2011
-
PMS74 Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, CanadaRoussy, J. P. / Bessette, L. / Bernatsky, S. / Rahme, E. / Lé / garé / J. / Lachaine, J. et al. | 2011
-
PND17 Treatment Experience, Burden, and Unmet Needs (Tribune) in Multiple Sclerosis Study: Excess Burden Due to RelapsesKarampampa, K. / Gustavsson, A. / Miltenburger, C. / Eckert, B. et al. | 2011
-
PND15 Economic Burden of Chronic Migraine in TaiwanTang, C. H. / Chen, Y. C. / Wang, S. J. / Ng, K. et al. | 2011
-
PND38 International Comparison of Huntington Disease (HD) BurdenDorey, J. / De Nicola, N. / Tedroff, J. / Squitieri, F. / Clay, E. / Verny, C. / Zielonka, D. / Cohen, J. / Aballea, S. / Lamure, M. et al. | 2011
-
PND52 Responsiveness of the Multiple Sclerosis International Quality of Life and Short Form-36 Questionnaires to Expanded Disability Status Scale Score Changes in Subjects with Multiple Sclerosis: Final 24-Month Results From An International Observational StudyFernandez, O. / Baumstarck-Barrau, K. / Butzkueven, H. / Flachenecker, P. / Idiman, E. / Pelletier, J. / Stecchi, S. / Verdun di Cantogno, E. / Milner, A. / Auquier, P. et al. | 2011
-
PUK15 A Simulation Model of The Effects of Treatments for Secondary Hyperparathyroidism on MortalityIannazzo, S. / Pradelli, L. / Chiroli, S. / Pé / tavy, F. / Briggs, A. et al. | 2011
-
PHP6 Regional Variability in the Generic Antidepressant Market in SpainEspinó / s, B. / Vieta, A. / Hurtado, P. / Badia, X. et al. | 2011
-
PHP13 A Survey of Pricing Trends Around the WorldReinaud, F. / Ando, G. et al. | 2011
-
PHP15 Price Negotiations in Korean Pharmaceutical Benefit System: How Compatible with CEA?Kwon, H. et al. | 2011
-
PHP16 Extrapolating Strategic Insights Through Market Segmentation: A Conceptual FrameworkForster, L. / Wild, L. et al. | 2011
-
PHP24 How Does the Committee to Evaluate Drugs (CED) Make Decisions about Ambulatory Pharmaceutical Funding in Ontario?Sim, J. / Speicher, J. / Evans, G. / Mahar, A. L. / Johnson, A. et al. | 2011
-
PHP27 Diffusion of Innovations in Health Care: Does the Dual Market Phenomenon Exist?Arbel, R. / Yogev, G. / Greenberg, D. et al. | 2011
-
PHP38 Market Access for Pharmaceuticals in UK: Number and Speed of Drug Reviews to Improve After Introduction of Value Based PricingIzmirlieva, M. A. / Ando, G. / Bharath, A. et al. | 2011
-
PHP55 A Review of the Nice Appeals ProcessEaton, J. N. / Hawkins, N. et al. | 2011
-
PHP66 Impact of Type of Drug Insurance on the Use of Health Care Services Among Users of AntidepressantsBlais, L. / Perreault, S. / Lalonde, L. / Bé / rard, A. / Moisan, J. / Rahme, E. et al. | 2011
-
PHP98 Exploring Regional Variation in Tariffs/Public Prices Across Autonomous Communities in Spain: The Case of Diagnosis Related Groups and ICD-9 Diagnostic CodesRaluy, M. / De Cock, E. / Rovira, J. / Gimenez, E. / Albarracin, M. G. et al. | 2011
-
PHP105 Cost-Effectiveness in Drug Reimbursement Decision Making: A Toothless Tiger?Franken, M. / Sandmann, F. / Koopmanschap, M. et al. | 2011
-
PHP125 Clinical Trial Learning Curves May Impact Both Clinical and Economic Outcomes, and Influence Health Technology Assessment and Reimbursement Decision MakingSpinner, D. S. / Mladsi, D. M. / Walter, J. W. / Stafford-Smith, M. / Taekman, J. M. / Faulkner, E. C. et al. | 2011
-
PHP130 Using Economic Evidence and Stakeholder'S Participation in Decision Making on Benefit Package of Public Health insurance in ThailandPachanee, K. / Mohara, A. / Teerawattananon, Y. / Tantivess, S. / Lertiendumrong, J. / Prakongsai, P. et al. | 2011
-
PHP148 Global Pharmaceutical Risk-Sharing Agreement Trends in 2010 and 2011Ando, G. / Reinaud, F. / Bharath, A. et al. | 2011
-
PHP156 Novel Drug Reimbursement Models: Lessons and Implications from Cancer Drug Access SchemesAggarwal, S. et al. | 2011
-
PCV8 Effect of SIADH on Patient Outcomes and Health Care Resource Utilization in Hospitalized PatientsAmin, A. / Deitelzweig, S. / Lin, J. / Christian, R. / Baumer, D. / Lowe, T. et al. | 2011
-
PCV12 Differences in the Weighted Average Daily Doses of Statins in Europe and Their Potential Impact on Cardiovascular OutcomesLiew, D. / Webb, K. et al. | 2011
-
PCV20 Duration of Action of Aliskiren in Hypertensive Patients with Diabetes – Implications for Control of Blood Pressure in Real-World Use in Imperfectly Adherent PatientsLowy, A. / Brede, Y. et al. | 2011
-
PCV43 Budget Impact of the Implementation of a Treatment Protocol for Pulmonary Arterial Hypertension in A Referral HospitalVega-Coca, M. D. / Flores, S. / Bautista, J. et al. | 2011
-
PCV83 A Cost-Effectiveness Analysis of Ticagrelor in Patients with Acute Coronary Syndrome in GreeceKritikou, P. / Yfantopoulos, J. et al. | 2011
-
PCV114 Preferences for Communication Outcomes Following a StrokeDavies, L. M. et al. | 2011
-
PCV121 The Economic and Humanistic Burden of Acute Coronary Syndrome (ACS): A Systematic ReviewWeir, S. / Ratcliffe, M. / Mollon, P. / Langham, S. / Ossa, D. et al. | 2011
-
PCV126 Multidimensional Non-Interventional Study to Assess Current Practice, Utilization of Resources and Costs Related to Anticoagulation Treatment in Poland – “Economedica”Wilczynska, J. / Haldas, M. / Bolisega, D. / Rutkowski, J. / Smaga, A. / Wladysiuk, M. et al. | 2011
-
PCV127 Time to Initiation of Oral Antihyperglycaemic and Statin Therapy in Patients with Newly Diagnosed Type 2 Diabetes MellitusTunceli, K. / Sun, P. / Seck, T. / Ambegaonkar, B. / Lento, K. / Davies, M. J. / Zhang, Q. / Radican, L. et al. | 2011
-
PCV136 Factors Associated with Failing to Achieve Low Density Lipoprotein Cholesterol Goal with Existing Statin Therapy: A Chart Extraction-Based ApproachZhao, Z. / Ivanova, J. / Bae, J. P. / Boykin, S. D. / Mccracken, R. / Molife, C. / Waldman, T. / Frois, C. et al. | 2011
-
PCV140 The Impact of National Mass Screening Program on Health Service Utilizations and Medical Expenses: In the Case of Hypertension ComplicationsHong, J. M. / Lee, T. J. et al. | 2011
-
PGI4 Cost-Effectiveness of Esomeprazole Versus Pantoprazole in Acute and Maintenance Treatments of Reflux Esophagitis in TurkeyOrmeci, N. / Caglayan, B. et al. | 2011
-
PGI20 Pharmacoeconomic Study of Glutamine Dipeptide Usage During Total Parenteral Nutrition (TPN)Metelkin, I. / Yagudina, R. / Kulikov, A. et al. | 2011
-
PSY1 Tolerability of Oral Long-Acting Opioids in the Treatment of Chronic Pain: a Systematic Literature Review and Meta-AnalysisNalysnyk, L. / Kavanagh, S. / Xu, Y. / Mercaldi, K. / Martin, A. / Merchant, S. et al. | 2011
-
PSY5 A Systematic Review of Tapentadol in Chronic Moderate to Severe PainRiemsma, R. / Forbes, C. / Harker, J. / Misso, K. / Liedgens, H. / Schaefer, M. / Kleijnen, J. et al. | 2011
-
PSY9 A Budget Impact Model of Rituximab Introduction in Wegener Granulomatosis TherapiesNdir, A. / Pagnoux, C. / Mahr, A. / Guillevin, L. / Vidal-Tré / can, G. et al. | 2011
-
PSY11 Budget Impact Model of Hemophilia a Treatment in Turkey: a Payer'S PerspectiveKayadibinli, M. / Ulus, P. / Durguner, B. et al. | 2011
-
PSY12 Comparison of the Most Common Reasons for Inpatient Admissions Among Fibromyalgia Patients on Duloxetine Versus PregabalinZhao, Y. / Sun, P. / Sun, S. et al. | 2011
-
PRM13 Assessing the Methods for Systematic Reviews of Economic EvaluationsPaone, S. / Di Tanna, G. L. / Corio, M. / Jefferson, T. / Cerbo, M. / Migliore, A. et al. | 2011
-
PRM15 The Outcome of ISPOR European and International Congresses Between 2005-2009Boncz, I. / Sebestyen, A. / Kriszbacher, I. et al. | 2011
-
PRM45 Importance of Collaboration with Developers in the Clarification of Concepts: A Case Study with the University of California, San Diego (UCSD) Shortness of Breath Questionnaire (SOBQ)Ries, A. L. / Kaschinski, D. / Montigny, C. et al. | 2011
-
PCN15 Dance as Physiotherapy in the Rehabilitation of Women Suffering from TumourSzalai, M. / Szirmai, A. / Fuchs, N. / Boncz, I. / Szalai, T. / Kriszbacher, I. et al. | 2011
-
PCN26 Long-Term Fiscal Implications of Mepact in the Treatment of High-Grade Non-Metastatic Osteosarcoma: A Budget Impact Model and A Lifetime Tax PerspectiveJohal, S. / Knight, C. / Bell, M. J. / Ralston, S. et al. | 2011
-
PCN25 Budget Impact Analysis of Switching to Digital Mammography in A Breast Cancer Population-Based Screening ProgramArrospide, A. / Comas, M. / Mar, J. / Sala, M. / Hernandez, C. / Roman, R. / Castells, X. et al. | 2011
-
PCN33 Cost Analysis: Treatment of Chemotherapy-Induced Anaemia with Erythropoiesis-Stimulating Agents (ESAs) in SpainDuran, A. / Spaepen, E. / Lamotte, M. / Brosa, M. / Gutierrez, L. / Restovic, G. / Annemans, L. et al. | 2011
-
PCN42 Treatment Costs of Bone Metastases in Patients with Lung Cancer: Results From A French Prospective, Observational, Multicenter Study (GFPC 0601)Borget, I. / Decroisette, C. / David, P. / Fournel, P. / Locher, C. / Grangeon, V. / Thomas, P. / Barlesi, F. / Bombaron, P. / Chouaid, C. et al. | 2011
-
PCN51 Health Care Resources and Costs Across Lines of Therapies in Insured Patients with Metastatic Breast Cancer in the United StatesBonthapally, V. / Ganguli, A. / Landsman-Blumberg, P. / Mcmorrow, D. / Ray, S. et al. | 2011
-
PCN52 Economic Impact of Healthcare Resource Utilisation Patterns Among Patients Diagnosed with Advanced Melanoma in the UK, Italy, and France: Results From a Retrospective, Longitudinal Survey (Melody Study)Johnston, K. / Levy, A. / Lorigan, P. / Maio, M. / Lebbé / C. / Middleton, M. / Testori, A. / Bé / dane, C. et al. | 2011
-
PCN71 Value of Progression-Free Survival (PFS) in Refractory Non-Small Cell Lung Cancer (NSCLC): An Exploratory Modeling AnalysisFerrufino, C. P. / Foley, D. / Trochlil, K. / Munakata, J. et al. | 2011
-
PCN82 Cost-Effectiveness Analysis of Trastuzumab + Docetaxel Versus Docetaxel Alone in the Treatment of HER2+ Metastatic Breast CancerAthanasakis, K. / Golna, C. / Kyriopoulos, J. et al. | 2011
-
PCN87 The Cost Effectiveness of Cetuximab (Erbitux) in the Third Line Treatment of Metastatic Colorectal Cancer in the UKPerard, R. / Samyshkin, Y. / Guillermin, A. L. et al. | 2011
-
PCN101 A Cost-Effectiveness Analysis for Second-Line Treatment of Relapsed/Refractory (RR) Multiple Myeloma (MM) in the United KingdomJiang, Y. / Spencer, M. / Gauthier, A. / Pacou, M. et al. | 2011
-
PCN108 Economic Evaluation of Sunitinib Malate for the First-Line Treatment of Metastaric Renal Cell Carcinoma in the Chinese Health Care SettingWu, J. / Zhang, N. / Dong, P. et al. | 2011
-
PCN164 Does Different Availability of Oncology Care is Responsible for Differences in Cancer-related Mortality Rates Among the Provinces of Poland?Macioch, T. / Paweska, J. / Niewada, M. / Hermanowski, T. R. et al. | 2011
-
PCN184 Trends in Chemotherapy and Biologic Treatment of US Colorectal Cancer PatientsMeyer, N. / Weldon, D. / Huse, D. M. et al. | 2011
-
PCN191 Economic Evaluation of XELOX vs FOLFOX4 as Adjuvant Treatment for Patients with Stage III Colon Cancer in south KoreaKim, C. M. / Ju, S. Y. / Kim, S. H. / Kang, M. / Park, J. / Choi, W. S. et al. | 2011
-
PDB1 Association Between Hypoglycemia and Medication Possession Ratio Among Veterans with Type 2 Diabetes Mellitus (T2DM)Zhao, Y. / Shi, L. / Fonseca, V. / Campbell, C. / Wu, E. Q. et al. | 2011
-
PDB3 Hypoglycaemia-Related Emergency Department Visits and Hypoglycaemia-Related Hospitalizations Among News Users of Antidiabetes TreatmentsMoisan, J. / Breton, M. C. / Gregoire, J. P. et al. | 2011
-
PDB6 Description of Comorbidities and Body Mass Index in US Adults with and Without Diabetes from the Medical Expenditure Panel Survey, 2008Mitchell, B. et al. | 2011
-
PDB34 Medical Treatment Costs Attributable to Obesity in Diabetic Patients in the United StatesSuh, D. C. / La, H. O. / Yi, S. Y. / Choi, I. S. / Sohn, H. S. / Jang, S. M. et al. | 2011
-
PDB47 Understanding the Implications of Incorporating the UKPDS Glycaemic Legacy Effect Into Evaluating the Cost-Effectiveness of Type 2 Diabetes TherapiesMcEwan, P. / Prettyjohns, M. / Bergenheim, K. et al. | 2011
-
PDB72 The Burden of Hypoglycaemia in Secondary Care in EnglandHeller, S. / Tilling, C. et al. | 2011
-
PDB65 Unmet Need and Drug Management Challeneges in Elderly Type 2 Diabetes Medicare Part D PopulationKuan, R. / Schwartz, E. L. / Davis, E. A. / Schnecker, A. M. et al. | 2011
-
PDB78 Reasons of UK General Practitioners for Prescribing 15- or 30-Mg of Pioglitazone in Combination with Other Oral Antihyperglycaemic AgentsTunceli, K. / Lento, K. / Zhang, Q. / Jameson, K. / Meiler, S. / Davies, M. J. / Steinberg, H. / Brodovicz, K. / Radican, L. / Sinclair, A. et al. | 2011
-
PDB83 The Epidemiology and Burden of Obesity and Diabetes in France: A Methodological ComparisonMoisan, C. / Eschwè / ge, E. / Basdevant, A. / Charles, M. A. / DiBonaventura, M. D. / Bonné / lye, G. et al. | 2011
-
PRS3 The Effect Of Aat Replacement Therapy on Patient Length And Quality Of Life - a Markov ModelBatty, A. J. / Tolley, K. / Jain, M. / Ruebesam, T. / Winn, B. et al. | 2011
-
PRS8 Predicted Survival for North American Patients with Cystic Fibrosis Adjusted for Cohort Specific CovariatesBecker, C. C. / Li, H. / Harrow, B. / Liou, T. G. et al. | 2011
-
PRS22 Estimation of Direct and Inderct Costs of COPD in Ukraine: The Pilot Study ResultsTolubaiev, V. / Zalis' / ka, O. / Ostrovskyy, M. / Korzh, G. / Yakovenko, O. / Holovatyuk, I. et al. | 2011
-
PRS40 Cost-Utility of Fluticasone Compared with Beclomethasone and Budesonid in Chronic Obstructive Pulmonary Disease (COPD) in PolandBolisega, D. / Dziewiatka, M. / Fedyna, M. / Ziobro, M. / Rutkowski, J. / Haldas, M. / Barlog, D. / Dziurda, D. / Glogowski, C. / Rys, P. et al. | 2011
-
PSS34 Qualitative Grounding for A New Patient Assessment Measure in Ophthalmology: The Functional Assessment of Visual Tasks (Vistas)Atkinson, M. J. / Tally, S. / Heichel, C. W. / Kozak, I. et al. | 2011
-
PSS40 The Effect of Acute Otitis Media in Children on Parents' Quality of Life: Development and Validation of A Questionnaire Implemented in A Prospective Observational Cohort Study in EuropeLiese, J. G. / Giaquinto, C. / Silfverdal, S. A. / Carmona, A. / Larcombe, J. / Garcia-sicilia, J. / Fuat, A. / Muñ / oz Hiraldo, E. / Arroba basanta, M. L. et al. | 2011
-
PSS46 Availability of Resources for Patients With Wet Age-Related Macular Degeneration: Optimal StudyBalañ / M. / Lahoz, R. / Casaroli-marano, R. P. / Roura, M. et al. | 2011
-
CV2 Cost-Effectiveness of Prasugrel Versus Clopidogrel in Patients with Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention in the Private Sector in MéxicoMondragon, R. / Arrieta-Maturino, E. / Vargas-Valencia, J. J. / Ramí / rez-Gá / mez, J. / Martí / nez-Fonseca, J. / Guzman-Sotelo, M. et al. | 2011
-
TP3 Patrones De Tratamiento Y Costos De atencion En Pacientes Con Artritis Reumatoide, Desde La perspectiva Del Proveedor De Servicios De Salud En MéxicoContreras, I. / Juarez-Garcia, A. / Martinez-Rivera, G. / Vallejos Pará / s, A. / Ojeda Mé / ndez, J. / Villasis-Keever, A. / Rangel, S. et al. | 2011
-
IN3 Dengue MÁs Que Un Problema De Salud PÚblica: EstimaciÓn De Los Costos Directos De La Epidemia Del AÑo 2010 En ColombiaBello, S. L. / Dí / az, E. / Malagon, J. N. / Romero, M. / Salazar, V. et al. | 2011
-
PCN2 Cost-Effectiveness and Budget Impact Analysis of an Immediate Care Center at the National Cancer Institute, MexicoNieves, U. / Guajardo, J. / Cerezo, O. / Plancarte, R. / Apodaca, A. / Torres, J. / Rodriguez, F. et al. | 2011
-
PHP4 Significant Decrease in the Hungarian Health Insurance Pharmaceutical Budget Between 2006-2009Boncz, I. / Donka-Verebes, x. / Oberfrank, F. et al. | 2011
-
PHP15 Implications of Latin American Pharmaceutical Pricing Reform for the UK NHSShankland, B. D. / Kirpekar, S. et al. | 2011
-
PHP25 Validity and Reliability of Instruments Used for Measuring Patient Satisfaction with Pharmaceutical Care ServicesSakharkar, P. R. / Bounthavong, M. / Law, A. V. et al. | 2011
-
PHP44 Characteristics of Patients Treated for Fibromyalgia in Puerto Rico and the United States: Baseline Findings of the Reflections Study (Real World Examination of Fibromyalgia: Longitudinal Evaluation of Costs and Treatments)Vazquez-Suarez, J. E. / Able, S. L. / Gatz, J. L. / Robinson, R. L. et al. | 2011
-
PMH5 Analisis De Costo Efectividad Del Manejo Farmacologico De La Esquizofrenia Recurrente En Peru Ajustado Por La Adherencia Ai TratamientoIzquierdo, C. et al. | 2011
-
AD2 Cost-Consequence Analysis of Switching From An Oral Antipsychotic To Long Acting Injectable Risperidone Among Patients With SchizophreniaDegli Esposti, L. / Sangiorgi, D. / Buda, S. et al. | 2011
-
DA4 Finding Treatment Effects within Subgroups when Using the propensity Score to Control for Selection Bias: A Monte Carlo Simulation Studyvan Eeren, H. / Spreeuwenberg, M. D. / van Manen, J. G. / de Rooij, M. / Stijnen, T. / Busschbach, J. et al. | 2011
-
PC4 Health Services Utilization, Work absenteeism and Costs of Pandemic influenza A (H1N1)Garin, O. / Galante, M. / Sicuri, E. / Cots, F. / Garcia-Alté / s, A. / Ferrer, M. / Nebot, M. / Dominguez, x. / Alonso, J. et al. | 2011
-
PR4 Analysis of Price Levels of Prescription Drugs and Determinants of international Price Differences between the United States and Selected European CountriesKanavos, P. / Vandoros, S. / Ferrario, A. et al. | 2011
-
MT2 The Use of Continuous Data versus Categorical Data in MTC: The Case of HAQ Multiplier in Rheumatoid ArthritisSchmitz, S. / Adams, R. C. / Walsh, C. / Barry, M. et al. | 2011
-
NI1 The UK Nice Single Technology Appraisal Process: A Qualitative Study Based on Manufacturers' SubmissionsKaltenthaler, E. et al. | 2011
-
HG3 Cost Comparisons and Methodological Heterogeneity in Cost-of-Illness Studies: The Example of Colorectal CancerHanly, P. / O' / Ceilleachair, A. / Skally, M. / Neill, C. / Sharp, L. et al. | 2011
-
PMD7 Effectiveness and Self-Monitoring of Blood Glucose (SMBG) Frequencies in Poorly-Controlled Patients with Non-insulin-Treated Diabetes (NITDM) Who Were Not Active Testers Prior to the Step StudyBerndt, K. / Jelsovsky, Z. / Rees, C. / Mast, O. et al. | 2011
-
PMD6 Efficacy and Safety of Artificial Disc Arthroplasty Compared to Surgical Fusion for Single Level Cervical and Lumbar Degenerative Disc Disease: A Bayesian Meta-analysisStam, W. / Alvares, L. / Birinyi-strachan, L. / Maetzel, A. et al. | 2011
-
PMD15 Societal Costs of Routine Follow-up Services for Cardiac Implantable Electrical Devices in Germany and the United Kingdom - and the Impact of remote MonitoringSmala, A. / Gessler, M. / Stoepel, C. et al. | 2011
-
PMD17 Noble Metal Alloy-Coated Urethral Catheter: A Budget Impact analysis in the Veneto Region of ItalyFantelli, V. / Van de Vooren, K. / Curto, A. / Filippi, C. / Bassotto, F. / Garattini, L. / Scroccaro, G. et al. | 2011
-
PMD28 Cost-Effectiveness Analysis of Three Leprosy Case Detection Methods in Northern NigeriaEzenduka, C. C. et al. | 2011
-
PMD53 Pulmonary Vein isolation for the Treatment of Paroxysmal AF: Time reduction and productivity Gain with “anatomically-Designed” Cathethers Compared to “Point by Point” CathetersFagnani, F. / Coulomb, S. / Marcaud, N. / Bouchet, M. / Bonté / J. et al. | 2011
-
PMD70 A Review of the Geographic Variations in the Implant Rate of Transcatheter Aortic Valves in 14 European CountriesBusca, R. / Brasseur, P. / Hull, M. / Mealing, S. et al. | 2011
-
PSU17 Cost-Effectiveness of DSAEK Versus PK for Corneal EndothelialdiseasePatel, S. / Kaakeh, R. / Shtein, R. / Smith, D. et al. | 2011
-
PSU20 Estimating Preferences for Economic Evaluation in Patients with Localized Prostate CancerAvila, M. M. / Becerra, V. / Cunillera, O. / Pardo, Y. / Ferrer, M. et al. | 2011
-
PSU22 Performance of the Functional Assessment of Visual Tasks (VISTAS-18) among Cataract Patients Receiving Monofocal and Multifocal Intraocular Lens ImplantsHeichel, C. W. / Kozak, I. / Fellows, I. / Tally, S. / Atkinson, M. J. et al. | 2011
-
PIN19 Pharmacoeconomic Analysis of Pegylated Interferon Alfa Use in Chronic Hepatitis CRyazhenov, V. V. et al. | 2011
-
PIN22 Comparison of Two Dynamic Models Predicting Future Burden of Illness of Hepatitis C (HCV) in the EU-5 (France, Germany, Italy, Spain, UK)Kempel-Waibel, A. / Schwehm, M. et al. | 2011
-
PIN23 To Assess or Not To Assess: That is the Question! Budget, Ethical and Decisional Impact assessment in HIV: Lombardy Region's Molo ProjectRestelli, U. / Lazzarin, A. / Galli, M. / Rizzardini, G. / Scolari, F. / Vanzago, A. / Croce, D. / Foglia, E. et al. | 2011
-
PIN38 Guideline Evaluation of Costs Related to Chronic Hepatitis C and Antiviral Treatment StrategiesStahmeyer, J. T. / Krauth, C. / Abdelfattah, M. / Bert, F. / Rossol, S. et al. | 2011
-
PIN50 The Clinical Efficacy and Cost-Effectiveness of Boceprevir in Combination with Pegylated Interferon- Alfa and Ribavirin for the Treatment of Genotype 1 Chronic Hepatitis C Patients: A Within Trial Analysis from the Perspective of the Scottish National Health Service (NHS)Nikoglou, E. / Humphreys, S. / El khoury, A. / Ferrante, S. A. / O' Regan, C. et al. | 2011
-
PIN51 A Cost-Effectiveness Analysis of Linezolid Versus Vancomycin for Ventilator-Associated Pneumonia Patients in PanamaLutz, M. A. / Villalobos, D. / Morales, G. / Cuesta, G. et al. | 2011
-
PIN72 Cost-Effectiveness of Rotavirus Immunization in Vietnam: Results and ChallengesTu, H. A. / Rozenbaum, M. / Coyte, P. C. / Li, S. C. / Postma, M. J. et al. | 2011
-
PRM4 Measuring Comorbidity in Administrative DataHermansson, J. / Carlqvist, P. / Kennedy, K. / Pietri, G. et al. | 2011
-
PIN101 New Insights on the Spread of Influenza Through Agent Based Epidemic ModelingMiksch, F. / Urach, C. / Popper, N. / Zauner, G. / Endel, G. / Schiller-Frü / hwirth, I. / Breitenecker, F. et al. | 2011
-
PIN111 Dynamic Modeling of Cost-Effectiveness of 13-Valent Pneumococcal Conjugate Vaccination Against Streptococcus Pneumoniae in TaiwanChang, C. J. / Wu, D. B. / Fann, C. S. / Wen, Y. W. / Huang, Y. C. / Wu, C. L. et al. | 2011
-
PMH4 Extent of Attaining and Maintaining Symptom Remission by Antipsychotic Medication in the Treatment of Chronic Schizophrenia: Evidence from the Catie StudyLevine, S. Z. / Rabinowitz, J. / Ascher-Svanum, H. / Faries, D. / Lawson, T. et al. | 2011
-
PMH27 An Economic Analysis of the Impact of Crime and Hospitalisation Associated with Different Interventions for Opioid Abuse in the United KingdomTaylor, M. / Lewis, L. / Mckeganey, N. et al. | 2011
-
PMH39 Cost Effectiveness of A Collaboratieve Care Stepped intervention for Anxiety Disorders in the Primairy Care SettingGoorden, M. / Muntingh, A. / Balkom, A. J. / Van marwijk, H. W. / Spinhoven, P. / De waal, M. W. / Assendelft, P. J. / van der Feltz-Cornelis, C. M. / Hakkaart - van Roijen, L. et al. | 2011
-
PMH45 Comparison of the SF-6D and the EQ-5D in Patients with SchizophreniaMillier, A. / Perthame, E. / Aballea, S. / Toumi, M. et al. | 2011
-
PMS25 Evaluation of Direct Costs for the Treatment of Active Juvenile Rheumatoid Arthritis Using BiologicsYagudina, R. / Kulikov, A. / Zinchuk, I. et al. | 2011
-
PMS29 Abatacept or Infliximab for Patients with Rheumatoid Arthritis and Inadequate Response to Methotrexate: A Trial-Based and Real-Life Cost-Consequence AnalysisBenucci, M. / Stam, W. / Gilloteau, I. / Crocchiolo, D. / Sennfä / lt, K. / Leclerc, A. / Bengtsson, N. / Maetzel, A. / Lucioni, C. et al. | 2011
-
PMS37 The Cost Effectiveness of Glucosamine Sulphate Powder (Glusartel) for the Treatment of Osteoarthritis of the KneeBatty, A. J. / Birrell, F. et al. | 2011
-
PMS47 The Long Term Cost-Effectiveness of Golimumab for the Treatment of Severe, Active Ankylosing Spondylitis in Adults Who Have Responded Inadequately to Conventional TherapyFarrell, J. / Muszbek, N. / Sheppard, O. / Chaudhary, M. / Naci, H. / Kachroo, S. et al. | 2011
-
PMS52 Additional Medical Costs Due to Falls/Slips at Three Teaching Hospitals in JapanTsuda, Y. / Hirose, M. / Egami, K. / Honda, J. / Shima, H. / Imanaka, Y. et al. | 2011
-
PMS78 Measurement Strategy for Kyphosis: New Evidence from Patients and PhysiciansBayliss, M. S. / Miltenburger, C. / Van de Maele, C. / Alvares, L. / Bujanover, S. et al. | 2011
-
PND19 Cost Of The Relapse Of Multiple Sclerosis In SpainGubieras, L. / Casado, V. / Romero-Pinel, L. / Matas, E. / Bau, L. / Martí / nez-Yé / lamos, S. / Ló / pez, M. et al. | 2011
-
PND35 Belgian Cost-Utility Analysis of Gilenya® (Fingolimod) in the Management of Adults with Active Relapsing Remitting Multiple SclerosisDrieskens, S. / Moeremans, K. et al. | 2011
-
PND47 The Huntington Clinical Self-Reported Instrument (H-CSRI): Validation in Germany, Poland and USAClay, E. / Mraidi, M. / Toumi, M. / Tedroff, J. / Squitieri, F. / De Nicola, N. / Verny, C. / Cohen, J. et al. | 2011
-
PND54 Quality of Life Impairment, Disability, and Economic Burden Associated with Chronic Daily Headache Focussing on Chronic Migraine With or Without Medication Overuse: A Systematic ReviewLanté / ri-Minet, M. / Duru, G. / Mudge, M. / Cottrell, S. / Tilden, D. et al. | 2011
-
PND59 A Common Road Map for Rational Clinical and Policy Decisionmaking: Application of the MCDA-Based Evidem Framework to Growth Hormone Use in Patients with Prader-Willi SyndromeTony, M. / Goetghebeur, M. M. / Khoury, H. / Wagner, M. / Deal, C. L. / Battista, R. et al. | 2011
-
PUK6 BPH Patients Treated with Phytotherapy in Portugal: Results at Six MonthsPerrin, P. / Auges, M. / Rahhali, N. / Taieb, C. et al. | 2011
-
PHP33 Impact of 2011 German Health Care Reform on Global Market Access StrategiesHonoré / A. C. / Marinoni, G. / Ando, G. et al. | 2011
-
PHP63 Savings on Pharmaceutical Expenditure in Greek NHS Hospitals Under the Shadow of the International Monetary Fund (IMF)Karapanos, N. / Androutsou, L. / Dede, Z. / Geitona, M. et al. | 2011
-
PHP84 Assessing Productivity and Activity Impairment Due to Illness in Poland: Employees Versus Employers ViewWrona, W. / Hermanowski, T. / Jakubczyk, M. et al. | 2011
-
PHP94 Analysis of Results of the Reference Pricing of TurkeyKockaya, G. / Uman, N. / Vural, I. M. / Akbulat, A. / Ozbek, H. / Simsek, E. / Artı / ran, G. / Kerman, S. et al. | 2011
-
PHP96 Mitigating Emergency Department Over-Crowding Utilizing Focused Operations Management ToolsSchwartz, D. / Pliskin, J. S. / Goldberg, A. / Ronen, B. et al. | 2011
-
PHP169 The Values of General Practitioners/Family Physicians Should Be Fostered into Other Clinicians: A Research StudyHan-You, X. et al. | 2011
-
PCV3 Thromboprophylaxis Use and Venous Thromboembolism, Major and Minor Bleeding Event Analysis in Hospitalized Medically Ill PatientsBaser, O. / Wang, L. et al. | 2011
-
PCV16 Guidelines Adherent Pharmacotherapy Resulted in Better Hypertension ControlAhmad, N. / Hassan, Y. / Tangiisuran, B. / Meng, O. L. / Aziz, N. A. / Atif, M. / Saleem, F. et al. | 2011
-
PCV62 Influence of Smoking on the Use of Health-Care resources and Costs in Patients with Cardiovascular DiseaseSicras-Mainar, A. / Diaz-Cerezo, S. / Sanz de Burgoa, V. / Navarro-Artieda, R. et al. | 2011
-
PCV79 Economic Evaluation of Rosuvastatin Versus Atorvastatin, Simvastatin and Pravastatin in High Risk Patients Treated for Primary and Secondary Prevention of Cardiovascular Disease in GreeceFragoulakis, V. / Kourlaba, G. / Maniadakis, N. et al. | 2011
-
PCV101 Population Based Study : Impact of Adherence to Antihypertensive Agents on Cardiovascular IssuesPerreault, S. / Yu, A. Y. / Cô / té / R. / Dragomir, A. / White-guay, B. / Dumas, S. et al. | 2011
-
PCV132 Do Atrial Fibrillation (AF) Patients Get Oral Anticoagulation (OAC) as Guidelines Recom-Mend? An Analysis of German Health Insurance Claims DataWilke, T. / Mueller, S. / Groth, A. / Verheyen, F. / Linder, R. / Pfannkuche, M. / Breithardt, G. / Bauersachs, R. / Maywald, U. et al. | 2011
-
PGI9 Impact of Dysphagia on U.S. Hospital Charges in Patients with Comorbid ConditionsHelm, T. / Jensen, I. S. / Cyr, P. L. et al. | 2011
-
PGI29 Quality of Life in Chronic Liver DiseaseAnapaz, V. / Vicente, C. / Almeida, A. et al. | 2011
-
PIH3 Respiratory Syncytial Virus Hospitalizations in the Canadian Registry for Synagis (CARESS)Paes, B. A. / Li, A. / Lanctot, K. L. / Mitchell, I. et al. | 2011